{"id": "43", "boolean": "((\"Thyroid Neoplasms\"[MeSH] OR \"Adenocarcinoma, Follicular\"[MeSH] OR \"Adenocarcinoma, Papillary\"[MeSH] OR OPTC OR ((Thyroid[tiab] OR Follicular[tiab] OR Papillary[tiab] OR hurtle cell[tiab]) AND (cancer[tiab] OR cancers[tiab] OR carcinoma[tiab] OR carcinomas[tiab] OR Adenocarcinoma[tiab] OR Adenocarcinomas[tiab] OR neoplasm[tiab] OR neoplasms[tiab] OR nodule[tiab] OR nodules[tiab] OR tumor[tiab] OR tumour[tiab] OR Tumors[tiab] OR Tumours[tiab] OR cyst[tiab] OR cysts[tiab]))) AND (\"Autopsy\"[MeSH] OR \"Autopsy\"[tiab] OR \"Autopsies\"[tiab] OR \"Postmortem\"[tiab] OR Post-mortem[tiab] OR \"step-sectioned\"[tiab] OR \"step sectioned\"[tiab] OR  (Post[tiab] AND mortem[tiab])) AND (\"Prevalence\"[MeSH] OR \"Prevalence\"[tiab] OR \"Prevalences\"[tiab] OR Incidence[tiab] OR Epidemiology[tiab] OR Epidemiological[tiab] OR Frequency[tiab] OR Detected[tiab]) AND (\"Incidental Findings\"[MeSH] OR Incidental[tiab] OR Unsuspected[tiab] OR Discovery[tiab] OR Discoveries[tiab] OR Findings[tiab] OR Finding[tiab] OR Occult[tiab] OR Hidden[tiab] OR Latent[tiab] OR Consecutive[tiab]))", "generated_query": ["What is the effectiveness of autopsy and postmortem examination in detecting thyroid neoplasms, adenocarcinoma, follicular, papillary, and neoplasm, as well as tumors and cysts, and the associated symptoms such as weight loss and fever, and how do they compare to incidental findings, unintentional discovery, and sequential occurrence?", "What is the effectiveness of autopsy, postmortem, and step-sectioned examination in the diagnosis and management of thyroid neoplasms, adenocarcinia, follicular, papillary, and tumors, as well as their associated symptoms such as cancer, cysts, and neoplasm, and their associated metastasis?", "What is the effectiveness of autopsy or postmortem studies in the diagnosis and management of thyroid neoplasms, including adenocarcinoma, follicular and papillary tumors, as well as neoplasms and nodules, and how do these studies detect or diagnose incidental findings or discoveries, and how do they relate to prevalence and incidence in both humans and animals?", "What is the effectiveness of autopsy and postmortem studies in detecting and diagnosing thyroid neoplasms, adenocarcinia, and tumors, including those of the follicular, papillary, and hurtle cells, as well as cysts and nodules, and their associated symptoms such as cancer, neoplasms, and tumors, in patients with incidental findings or unsuspected conditions?", "What is the effectiveness of autopsy and postmortem procedures in the diagnosis and management of thyroid neoplasms, adenocarcinia, papillary, and follicular tumors, as well as neoplasms and nodules, and their associated symptoms such as cancer, cysts, and tumors, and how do they relate to prevalence and incidence, in conjunction with findings of incidental and unexpected discoveries?", "What is the effectiveness of autopsy or postmortem examination in the diagnosis and management of thyroid neoplasms or adenocarcinia, follicular or papillary, as well as other related conditions such as cancer, cysts, tumors, and neoplasms, in conjunction with the prevalence of incidental or unsuspected findings?", "What is the effectiveness of autopsy and prevalence studies in detecting thyroid neoplasms, adenocarcinia, papillary, and Hurthle cell cancer, as well as tumors and cysts, and their associated symptoms such as weight loss, fatigue, and headaches? Additionally, how do autopsy and prevalence studies provide incidental findings, unsupported symptoms, and hidden features of these conditions?", "What is the effectiveness of using autopsy, postmortem, and step-sectioned studies in the diagnosis and management of thyroid neoplasms, including adenocarcinoma, follicular, papillary, OPTC, and nodules, as well as tumors and cysts, in patients with incidental or unexpected findings?", "What is the effectiveness of autopsy and postmortem imaging in the detection and diagnosis of thyroid neoplasms, including adenocarcinoma, follicular, papillary, and Hurtle cells, as well as their associated tumors and cysts, in patients with incidental or unexpected findings?", "What is the effectiveness of autopsy, postmortem, and step-sectioned analyses in detecting thyroid neoplasms, adenocarcinia, and tumors, as well as cancer, cysts, and nodules, in patients with incidental findings or unrecognized symptoms?"]}
{"id": "96", "boolean": "(\"Thyroid Neoplasms\"[Mesh] OR \"Adenocarcinoma, Follicular\"[Mesh] OR \"Adenocarcinoma, Papillary\"[Mesh] OR OPTC OR ((Thyroid[tiab] OR Follicular[tiab] OR Papillary[tiab] OR hurtle cell[tiab]) AND (cancer[tiab] OR cancers[tiab] OR carcinoma[tiab] OR carcinomas[tiab] OR Adenocarcinoma[tiab] OR Adenocarcinomas[tiab] OR neoplasm[tiab] OR neoplasms[tiab] OR nodule[tiab] OR nodules[tiab] OR tumor[tiab] OR tumour[tiab] OR Tumors[tiab] OR Tumours[tiab] OR cyst[tiab] OR cysts[tiab]))) AND (\"Autopsy\"[Mesh] OR \"Autopsy\"[tiab] OR \"Autopsies\"[tiab] OR \"Postmortem\"[tiab] OR Post-mortem[tiab] OR (Post[tiab] AND mortem[tiab])) AND (\"Prevalence\"[Mesh] OR \"Epidemiology\"[Mesh] OR \"Prevalence\"[tiab] OR \"Prevalences\"[tiab] OR Epidemiology[tiab] OR Epidemiological[tiab] OR Frequency[tiab]) AND (\"Incidental Findings\"[Mesh] OR Incidental[tiab] OR Unsuspected[tiab] OR Discovery[tiab] OR Discoveries[tiab] OR Findings[tiab] OR Finding[tiab] OR Occult[tiab] OR Hidden[tiab]) ", "generated_query": ["What is the effectiveness of thyroid neoplasms and adenocarcinia in the diagnosis and management of thyroid cancer, adenocarcinia, carcinoma, cysts, and tumors, as well as their associated symptoms such as weight loss, lethargy, and headache, as compared to those found in autopsy, postmortem, and incidental findings?", "What is the effectiveness of thyroid neoplasms and adenocarcinomas, including cancer, tumors, cysts, and nodules, as well as incidental findings and autopsy results, in the diagnosis and management of cancer?", "What is the effectiveness of autopsy and postmortem studies in detecting thyroid neoplasms, adenocarcinoma, papillary, and Hurle cell tumors, as well as associated cancers, carcinomas, adenocarcinomas, neoplasms, nodules, and tumors, and their associated symptoms such as hypothyroxinemia and weight loss? Additionally, what is the prevalence and incidence of these tumors in autopsy and postmortem studies, and how do discoveries in these studies affect the diagnosis and management of thyroid neoplasms?", "What is the effectiveness of autopsy or postmortem studies in the diagnosis and management of thyroid neoplasms, adenocarcinoma, follicular, papillary, or hurtle cell cancer, as well as their associated symptoms such as pain, cysts, and tumors, and their associated conditions such as metastasis and neoplasia, and how do these findings compare to incidental or unexpected discoveries?", "What is the effectiveness of thyroid neoplasms and adenocarcinia, follicular, papillary, and OPTC, as well as their associated symptoms such as cancer, carcinoma, neoplasm, nodule, and tumors, in detecting and monitoring the progress of thyroid cancer, as compared to autopsy, postmortem, and incidence findings, and how do they impact the diagnosis and treatment of the disease?", "What is the effectiveness of autopsy, postmortem, and incidental findings in detecting and diagnosing thyroid neoplasms, adenocarcinoma, papillary tumors, and neoplasms, as well as cancer, carcinoma, cysts, and tumors, and their associated symptoms, such as those related to Thyroid Cancer, Hurtle Cell Carcinoma, Adenocarcinia, and Nodules, in patients with or without symptoms?", "What is the effectiveness of autopsy and postmortem findings in the diagnosis and management of thyroid neoplasms, adenocarcinia, follicular, papillary, OPTC, and nodules, as well as tumors and cysts, and their associated symptoms such as pain, swelling, and dysfunction?", "What is the effectiveness of autopsy, postmortem, and incidental findings in detecting thyroid neoplasms, adenocarcinia, and tumors, as well as their associated symptoms and complications, in patients with symptoms suggestive of thyroid disease?", "What is the effectiveness of autopsy, epidemiology, and findings of neoplasms such as thyroid cancer, adenocarcinoma, follicular adenocarcinoma, papillary adenocarcinoma, and neoplasms such as nodules, tumors, cysts, and autopsy prevalence in patients with unexpected findings?", "What is the effectiveness of using autopsy, postmortem, and prevalence data to detect thyroid neoplasms, adenocarcinoma, papillary tumors, and cysts, as well as their associated cancers, carcinomas, Adenocarcinia, neoplasms, nodules, tumors, and cysts, in patients with incidental findings or unsuspected tumors?"]}
{"id": "103", "boolean": "(\"Drug Resistance, Microbial\"[Mesh] OR \"Drug resistance\"[tiab] OR \"Drug resistant\"[tiab] OR \"multidrug-resistant\"[tiab] OR \"multidrug resistant\"[tiab] OR \"Microbial resistant\"[tiab] OR \"Microbial resistance\"[tiab] OR \"Antibiotic resistance\"[tiab] OR \"Antibiotic resistant\"[tiab] OR \"Antibacterial resistance\"[tiab] OR \"Antibacterial resistant\"[tiab] OR \"Antimicrobial resistance\"[tiab] OR \"Antimicrobial resistant\"[tiab]) AND (\"Urinary Tract Infections\"[Mesh] OR \"Urinary Tract Infections\"[tiab] OR \"Urinary Tract Infection\"[tiab] OR UTIs[tiab] OR UTI[tiab] OR Cystitis[tiab]) AND (\"Primary Health Care\"[Mesh] OR \"General Practice\"[Mesh] OR \"Primary health\"[tiab] OR \"Primary care\"[tiab] OR \"General practice\"[tiab] OR \"General practices\"[tiab] OR \"General practitioners\"[tiab] OR Community[tiab] OR \"Consultation rates\"[tiab] OR \"Re-consultation rates\"[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh])", "generated_query": ["What is the effectiveness of primary health care interventions for drug resistance in urinary tract infections, including those caused by Escherichia coli and Staphylococcus aureus, and how do randomized controlled trials or placebo-controlled studies compare to consultation rates or re-consultation rates for these microorganisms?", "What are the effects of primary healthcare interventions for urinary tract infections, including antibiotics and vaccines, as compared to placebo or other treatments, in reducing morbidity and mortality in both children and adults? Additionally, what is the effectiveness of primary healthcare interventions in reducing consultation and re-consultation rates, as well as randomized controlled trials and controlled clinical trials, and their associated follow-up and observations, for detecting and managing urinary tract infections?", "What is the effectiveness of drug resistance screening and management in detecting and preventing urinary tract infections, including cystitis, in patients at primary health care settings, as evaluated by randomized controlled trials and epidemiologic studies?", "What is the effectiveness of interventions for urinary tract infections, including antibiotics and vaccines, as compared to placebo or other treatments, in reducing morbidity and mortality in both children and adults? This is the topic of a randomized controlled trial or controlled clinical trial, as well as epidemiologic and case-control studies, and the results are summarized in this paper.", "What is the effectiveness of primary health care and randomized controlled trials or controlled clinical trials in the diagnosis and management of urinary tract infections?", "What is the effectiveness of drug resistance management strategies for the treatment of urinary tract infections, including cystitis, in primary health care settings, as evaluated through randomized controlled trials or cohort studies, and involving follow-up or observational data?", "What is the effectiveness of primary health care interventions for drug-resistant urinary tract infections, including cystitis, primary care and general practice consultation rates, randomized controlled trials, and follow-up observation?", "What is the effectiveness of primary health care in treating urinary tract infections, including cystitis and pyelonephritis, as compared to placebo or other treatments, in reducing morbidity and mortality in both children and adults? This question is investigated in randomized controlled trials and epidemiologic studies, as well as case-control and cohort studies.", "What is the effectiveness of interventions for drug resistance, including antibiotics and vaccines, for reducing morbidity and mortality in urinary tract infections? This includes randomized controlled trials, controlled clinical trials, and epidemiic studies, as well as case-control studies, cohort studies, and follow-up observations.", "What is the effectiveness of interventions for drug-resistant urinary tract infections, including antibiotics and vaccines, compared to placebo or other treatments, in reducing morbidity and mortality in both children and adults? This question is addressed in a randomized controlled trial or controlled clinical trial, as well as in epidemiologic studies, case-control studies, cohort studies, and follow-up observations, and is investigated by analysis of statistics and data."]}
{"id": "17", "boolean": "(\"Japan\"[Mesh] OR Japanese[tiab] OR Japan[tiab]) AND (\"Encephalitis\"[Mesh] OR Encephalitis[tiab] OR \"Brain Inflammation\"[tiab] OR \"Brain Inflammations\"[tiab] OR \"Rasmussen Syndrome\"[tiab] OR \"Rasmussen's Syndrome\"[tiab]) AND (\"Vaccines\"[Mesh] OR Vaccine[tiab] OR Vaccines[tiab] OR IXIARO[tiab] OR SA14-14-2[tiab]) AND (Inactivated[tiab] OR Immunogenicity[tiab] OR Attenuated[tiab] OR Live[tiab] OR \"Cell-derived\"[tiab] OR \"Cell derived\"[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR Crossover[tiab] OR \"Comparative Study\"[pt] OR \"Evaluation Study\"[pt] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Evaluated[tiab] OR Impact[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh])", "generated_query": ["What is the effectiveness of vaccines, including IXIARO and SA14-14-2, in the treatment of encephalitis, brain inflammation, Rasmussen Syndrome, or other related conditions?", "What is the effectiveness of vaccines, including the encephalitic virus IXIARO or the immunogenic and attenuated viruses SA14-14-2, for the treatment of encephalitis or brain inflammation? This includes randomized controlled trials, controlled clinical trials, and epidemiologic studies.", "What is the effectiveness of vaccines, including IXIARO and SA14-14-2, in the treatment of encephalitis, brain inflammation, and related conditions?", "What is the effectiveness of vaccines, including those for Encephalitis, Rasmussen Syndrome, and brain inflammation, in the prevention of these conditions? Additionally, are there any randomized controlled trials or controlled clinical trials that have investigated their efficacy?", "What is the effectiveness of vaccines, including IXIARO and SA14-14-2, in the treatment of encephalitis or brain inflammation?", "What is the effectiveness of vaccines, including IXIARO and SA14-14-2, in treating encephalitis, brain inflammation, and randomized controlled trials or controlled clinical trials? This question should be answered in light of the observation that vaccines may have an immunogenic or attenuated effect, as well as the use of cell-derived or cell-based vaccines, and that the treatment of encephalitis is important for health outcomes?", "What is the effectiveness of vaccines, including IXIARO and SA14-14-2, in the diagnosis and management of encephalitis, brain inflammation, and related conditions, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of vaccines, including IXIARO and SA14-14-2, in the diagnosis and treatment of encephalitis, brain inflammation, Rasmussen syndrome, and related conditions? This question can be answered through randomized controlled trials, controlled clinical trials, and placebo or other interventions.", "What is the effectiveness of vaccines, including the Japanese Encephalitis Vaccine (IXIARO) and SA14-14-2, in the treatment of brain inflammation or encephalopathy, as well as Rasmussen Syndrome or Rasmussen's Syndrome, and randomized controlled trials or placebo-controlled clinical trials?", "What is the effectiveness of vaccines in preventing encephalitis, brain inflammation, Rasmussen Syndrome, or related conditions?"]}
{"id": "40", "boolean": "(\"Education, Professional\"[Mesh] OR ((Medical[tiab] OR Biomedical[tiab] OR Health[tiab] OR Anatomy[tiab] OR Anatomical[tiab] OR Neuroanatomy[tiab] OR Pathology[tiab] OR Genetics[tiab] OR pharmacology[tiab] OR bacteriology[tiab] OR Histology[tiab] OR Biochemistry[tiab] OR microbiology[tiab] OR Neurology[tiab] OR \"Basic Science\"[tiab] OR \"Basic Sciences\"[tiab] OR Physiology[tiab] OR Physiological[tiab]) AND (Education[tiab] OR Educational[tiab] OR Curriculum[tiab] OR Training[tiab] OR Learning[tiab]))) AND (\"Students, Medical\"[Mesh] OR Students[tiab] OR Student[tiab]) AND (\"Virtual Reality\"[Mesh] OR \"Virtual Reality\"[tiab] OR \"Virtual Realities\"[tiab] OR \"Augmented reality\"[tiab] OR \"Spatial Computing\"[tiab] OR \"Mixed Reality\"[tiab] OR AR[tiab] OR VR[tiab] OR MR[tiab]) AND (Assessing[tiab] OR Assessments[tiab] OR Assess[tiab] OR Assessed[tiab] OR ((Knowledge[tiab]) AND (Evaluate[tiab] OR Evaluation[tiab] OR acquire[tiab] OR acquirement[tiab] OR Retention[tiab]))) NOT (Review[pt] OR \"Systematic review\"[pt] OR \"Systematic review\"[ti])", "generated_query": ["What is the effectiveness of virtual reality and augmented reality in assessing the education and training of medical students? This includes evaluating knowledge and retention, as well as reviewing and systematic research.", "What is the effectiveness of virtual reality and other related technologies in the assessment and education of medical students?", "What is the effectiveness of virtual reality, augmented reality, spatial computing, and mixed reality in the assessment and review of medical education curriculum, training, and learning, as well as the knowledge and retention of students?", "What is the effectiveness of virtual reality and augmented reality in the assessment and evaluation of medical students' knowledge and retention of basic sciences, including anatomy, pathology, genetics, pharmacology, bacteriology, histology, biochemistry, and microbiology, as well as their associated curriculum and learning outcomes?", "What is the effectiveness of virtual reality and spatial computing in assessing the knowledge and skills of medical students, as well as their retention and acquisition of information, as compared to traditional review or systematic review methods?", "What is the effectiveness of virtual reality (VR) and augmented reality (AR) in the education and training of medical students, as compared to traditional education methods, in assessing knowledge and evaluating the retention of information, as well as the acquisition and development of basic sciences and skills, including anatomy, pathology, and genetics, and their associated fields?", "What is the effectiveness of virtual reality and augmented reality in assessing medical students' knowledge and understanding of basic science and clinical education, as well as their physical and spatial skills, as compared to traditional review and systematic search techniques, and how do these technologies impact the development and acquisition of medical education?", "What is the effectiveness of virtual reality and augmented reality in evaluating and training medical students in anatomy, pathology, genetics, pharmacology, bacteriology, histology, biochemistry, microbiology, neurology, and basic science?", "What is the effectiveness of virtual reality and augmented reality in assessing and reviewing the knowledge and skills of medical students? This includes studies on educational curriculum, training, learning, and assessments, as well as their associated software and hardware, and the evaluation and retention of knowledge.", "What is the effectiveness of virtual reality and spatial computing in assessing the knowledge and competency of medical students, as well as their understanding and retention of basic science and clinical material, as compared to traditional methods of education and evaluation?"]}
{"id": "22", "boolean": "(\"rabies vaccines\"[Mesh] OR ((vaccination[Mesh]) AND (rabies[Mesh] OR \"rabies virus\"[Mesh])) OR ((Rabies[tiab]) AND (vaccine[tiab] OR Vaccines[tiab] OR Vaccination[tiab] OR Vaccinations[tiab] OR Immunise[tiab] OR Immunize[tiab] OR Immunisation[tiab] OR Immunization[tiab]))) AND (\"immunization, secondary\"[Mesh] OR \"antibodies, viral\"[Mesh] OR \"time factors\"[Mesh] OR secondary[tiab] OR booster[tiab] OR boost[tiab] OR boosters[tiab] OR boostability[tiab] OR titer[tiab] OR gmt[tiab] OR ((sero[tiab]) AND (conversion[tiab] OR protection[tiab])) OR seroconversion[tiab] OR seroprotection[tiab]) AND (\"administration and dosage\"[sh] OR Administer[tiab] OR Administered[tiab] OR Administration[tiab] OR Intramuscular[tiab] OR Intradermal[tiab] OR \"pre-exposure\"[tiab] OR \"pre exposure\"[tiab]) NOT (animals[Mesh] NOT humans[Mesh])", "generated_query": ["What is the effectiveness of secondary immunization or antibodies, viral or time factors, or titer or gmt, as compared to placebo or other vaccines, in preventing rabies or rabies virus, as well as other viruses, and how do these compare to primary immunization or antibodies, viral or time factors, or titer or gmt, in animals or humans? Additionally, what is the effectiveness of administration and dosage, and how do they compare to placebo or other vaccines, in preventing rabies or rabies virus, as well as other viruses, and how do these compare to primary immunization or antibodies, viral or time factors, or titer or gmt, in animals or humans?", "What is the effectiveness of rabies vaccines, including immunization, secondary antibodies, and time factors, in preventing rabies in both humans and animals?", "What is the effectiveness of secondary immunization with rabies vaccines, including vaccination and antibodies, in preventing rabies in humans and animals? Additionally, what are the time factors and dosage regimens associated with optimal immunity, as well as the administration and distribution of vaccines, and how do they compare to placebo or other treatments?", "What is the effectiveness of rabies vaccines and immunization programs in reducing morbidity and mortality in both animals and humans?", "What is the effectiveness of rabies vaccines, including vaccination and immunization, in preventing rabies in humans? This includes studies on immunization, secondary, and antibodies, viral, as well as time factors, secondary, and booster, and titer, gmt, and seroconversion. Additionally, what is the administration and dosage of the vaccines, including pre-exposure and humans, and how do they compare to placebo or other treatments?", "What is the effectiveness of rabies vaccines and immunization techniques, including antibodies and time factors, in preventing rabies or rabies virus? Additionally, what is the administration and dosage of vaccines, as well as their immunization techniques, for rabies prevention? Finally, what is the pre-exposure immunization of animals and humans to prevent rabies?", "What is the effectiveness of rabbies vaccines, including immunization, secondary antibodies, time factors, and administration and dosage, in preventing the rabies virus or the condition itself?", "What is the effectiveness of rabies vaccines, including vaccination, immunization, and secondary immunization, as compared to placebo or other interventions, in preventing rabies or the rabies virus? Additionally, what is the impact of time factors, including booster and titer, and administration and dosage, on the efficacy of rabies vaccines? Finally, what is the effectiveness of pre-exposure vaccines in preventing rabies or the rabies virus, and how do changes in serotype affect immunity?", "What is the effectiveness of rabies vaccines, including immunization, secondary antibodies, and time factors, in preventing rabies? Additionally, what is the administration and dosage of rabies vaccines, and how do they compare to placebo or other treatments, in preventing rabies in humans and animals?", "What is the effectiveness of rabies vaccines, including those that are immunization-boosting or titer-building, in preventing rabies or Rabies virus, as well as any related symptoms such as inflammation or necrosis, and how do they compare to placebo or other treatments, in humans or animals, at reducing morbidity and mortality in both children and adults?"]}
{"id": "47", "boolean": "( Deprescriptions[Mesh] OR Deprescription[tiab] OR Deprescribing[tiab] OR Deprescribe[tiab] OR Deprescribed[tiab] OR ((Inappropriate[tiab] OR Ceased[tiab] OR Cease[tiab] OR Substituted[tiab] OR Reduce[tiab] OR Reduced[tiab] OR Reduction[tiab] OR Stopped[tiab] OR Stop[tiab] OR Discontinue[tiab] OR Discontinued[tiab] OR Discontinuing[tiab] OR Withdraw[tiab] OR Withdrawing[tiab] OR Withdrawl[tiab] OR Withdrawal[tiab]) AND (Medication[tiab] OR Medications[tiab] OR Polypharmacy[Mesh] OR Polypharmacy[tiab] OR Prescribing[tiab])) ) AND (Aged[Mesh] OR Elderly[tiab] OR Older[tiab] OR Old[tiab]) AND (\"Terminal Care\"[Mesh] OR \"Nursing Homes\"[Mesh] OR \"Frail Elderly\"[Mesh] OR \"Aged care\"[tiab] OR Life[tiab] OR \"Last year\"[tiab] OR Hospitalization[tiab] OR Hospitalisation[tiab] OR Hospitalized[tiab] OR Hospitalised[tiab] OR Chronic[tiab]) AND (Effective[tiab] OR Effectiveness[tiab] OR Efficacy[tiab] OR Reduction[tiab] OR Implemented[tiab] OR Benefit[tiab] OR Adverse[tiab]) AND ((\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Cohort Studies\"[Mesh] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Investigated[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]) OR (((Search[tiab] OR Searched[tiab]) AND (PubMed[tiab] OR MEDLINE[tiab])) OR (systematic[tiab] AND review[tiab]) OR ((systematically[tiab] OR reviewed[tiab]) AND literature[tiab]) OR meta analysis[Publication Type]) OR (\"Cochrane Database Syst Rev\"[journal])) AND (\"Hospitals\"[Mesh] OR \"Hospital Medicine\"[Mesh] OR \"Intensive Care Units\"[Mesh] OR Hospitalization[tiab] OR Hospitalisation[tiab] OR Hospitalized[tiab] OR Hospitalised[tiab] OR Hospital[tiab] OR \"Intensive care\"[tiab])", "generated_query": ["What is the effectiveness of deprescriptions and medication polypharmacy interventions in reducing morbidity and mortality in aged and elderly individuals, including those in nursing homes, frail elderly, and those with terminal care, as evaluated by randomized controlled trials, controlled clinical trials, and placebo or other interventions, as well as follow-up, longitudinal, and prospective studies, and involving hospitals, intensive care units, and randomized controlled trials?", "What is the effectiveness of deprescriptions and medication interventions, including randomized controlled trials and cohort studies, for the appropriate management of prescribing and adverse effects in elderly patients in terminal care or nursing homes, frail elderly, or with impaired functioning?", "What is the effectiveness of deprescribing medication in aged care, nursing homes, and hospitalization to reduce adverse effects and improve the quality of care for frail elderly? This includes randomized controlled trials, controlled clinical trials, and follow-up data from cohort studies.", "What is the effectiveness of deprescribing medications in aged care facilities, including nursing homes, frail elderly, and hospitalized patients, as compared to placebo or other interventions, in reducing morbidity and mortality in hospitalized patients? This includes randomized controlled trials or follow-up studies, and a search of the literature or meta-analysis of studies in the Cochrane Database of Systematic Reviews.", "What are the most effective ways to reduce medication use and polypharmacy in elderly patients in hospitals and nursing homes, including randomized controlled trials and cohort studies, as compared to placebo or other treatments, in reducing morbidity and mortality in patients with frail elderly, terminal care, and follow up?", "What is the effectiveness of medication deprescriptions or deprescriptions or withdrawals or reduction or implementation or benefit or adverse events in reducing morbidity and mortality in elderly patients in hospitalized settings?", "What is the effectiveness of deprescriptions, medication polypharmacy, and terminal care or nursing homes for the elderly or frail elderly, as well as those with chronic illness, and who are hospitalized or who have recently been hospitalized? This includes randomized controlled trials, controlled clinical trials, and follow-up or follow-up studies.", "What are the most effective methods for reducing inappropriate medication use and polypharmacy in elderly patients in terminal care facilities, including nursing homes, frail elderly, aged care, life, and last year? This question can be answered by randomized controlled trials or controlled clinical trials, as well as cohort studies and follow-up, with outcomes including reduction of adverse effects or hospitalization, and impact of literature and meta-analysis on the results.", "What is the effectiveness of medication interventions for the elderly, including terminal care, nursing homes, frail elderly, and those with Aged care, Life, and Last year, as compared to placebo or other interventions, for reducing morbidity and mortality in hospitals, intensive care units, and other care settings? This includes randomized controlled trials or follow-up studies, and data from the Cochrane Database or Hospital Medicine.", "What is the effectiveness of deprescriptions or deprescribing or medication reduction or implementation of randomized controlled trials or placebo interventions or follow-up or prospective or longitudinal or investigation or statistics or data or hospitalization or randomness or trial or groups or cohort or orphaned or impaired or and withdrawn or withdrawnal or withdrawnl or withdraul or withdraulll) in reducing morbidity or mortality in patients with Aged, Elderly, Older, or Frail Elderly?"]}
{"id": "102", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab]) AND (\"Sepsis\"[Mesh] OR Sepsis[tiab] OR \"Septic shock\"[tiab] OR \"Systemic inflammatory response syndrome\"[tiab] OR Septicemia[tiab] OR Septicemias[tiab]) AND (\"Mortality\"[Mesh] OR \"Survival Rate\"[Mesh] OR \"Survival Analysis\"[Mesh] OR Mortality[tiab] OR Death[tiab] OR Deaths[tiab] OR Survival[tiab]) AND (\"Emergency Service, Hospital\"[Mesh] OR \"Emergency service\"[tiab] OR \"Emergency services\"[tiab] OR \"Emergency department\"[tiab] OR \"Emergency departments\"[tiab] OR \"Emergency Units\"[tiab] OR \"Emergency Unit\"[tiab] OR ED[tiab] OR \"Intensive Care Units\"[Mesh] OR \"Intensive Care Units\"[tiab] OR \"Intensive Care Unit\"[tiab] OR ICU[tiab] OR ICUs[tiab]) AND (\"Time-to-Treatment\"[Mesh] OR Timing[tiab] OR \"Time to\"[tiab] OR Hour[tiab] OR Hours[tiab]) AND (Administration[tiab] OR Appropriate[tiab] OR Appropriateness[tiab] OR Compliance[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])", "generated_query": ["What is the effectiveness of anti-bacterial agents and antibiotics in the treatment of sepsis, systemic inflammatory response syndrome, and associated complications such as mortality, survival rate, and follow-up observations? Additionally, what is the timeliness of their administration, as evaluated in randomized controlled trials and epidemiologic studies?", "What is the effectiveness of anti-bacterial agents, including antibiotics and antibacterials, in the diagnosis and treatment of sepsis, systemic inflammatory response syndrome, and related conditions? This includes the question of when and how these agents should be administered, as well as their randomized controlled trials and epidemiologic studies, and the impact of animal studies on their effectiveness.", "What is the effectiveness of anti-bacterial agents, including antibiotics and vaccines, in reducing morbidity and mortality in both humans and animals? This includes randomized controlled trials or controlled clinical trials, as well as epidemiologic studies or case-control studies, and follow-up observation or longitudinal studies.", "What are the effectiveness of anti-bacterial agents, including antibiotics and antimicrobials, in the treatment of sepsis, systemic inflammatory response syndrome, septicemia, and death or mortality in emergency service hospital units?", "What are the most effective anti-bacterial agents or antibiotics or anti-microbials or antimicrobials for the treatment of sepsis or systemic inflammatory response syndrome, including time-to-treatment and compliance with randomized controlled trials or controlled clinical trials, as well as epidemiologic studies and follow-up observations? Additionally, what are the most effective emergency service, hospital, intensive care units, and time-to-treatment for the administration of anti-bacterial agents or antibiotics or anti-microbials, and how do they compare to placebo or other interventions, in reducing morbidity and mortality in humans?", "What is the effectiveness of anti-bacterial agents, including antibiotics and antibiotic compounds, in the treatment of sepsis or systemic inflammatory response syndrome, and how do they compare to placebo or other interventions, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of anti-bacterial agents, including antibiotics and antibacterials, in the treatment of sepsis, systemic inflammatory response syndrome, and mortality or death in hospital emergency services, intensive care units, and follow-up studies?", "What is the effectiveness of anti-bacterial agents, including antibiotics, antibacterials, and other medications, in the treatment of sepsis or systemic inflammatory response syndrome, as well as related conditions such as mortality, survival rate, and follow-up? This includes randomized controlled trials or controlled clinical trials, as well as epidemiologic studies, case-control studies, cohort studies, and follow-up.", "What is the effectiveness of anti-bacterial agents (including antibiotics and antimicrobials) in treating sepsis, systemic inflammatory response syndrome, and related conditions? This includes randomized controlled trials and follow-up studies.", "What is the effectiveness of anti-bacterial agents, including antibiotics and vaccines, in the diagnosis and treatment of sepsis, systemic inflammatory response syndrome, septicemia, and death in humans?"]}
{"id": "60", "boolean": "(Bandages[Mesh] OR Alginates[Mesh] OR Hydrogels[Mesh] OR Silver[Mesh] OR \"Silver Sulfadiazine\"[Mesh] OR Honey[Mesh] OR \"Collagenases\"[Mesh] OR Bandage[tiab] OR Bandages[tiab] OR Dressing[tiab] OR Dressings[tiab] OR Pad[tiab] OR Pads[tiab] OR Gauze[tiab] OR Tulle[tiab] OR Film[tiab] OR Films[tiab] OR Alginate[tiab] OR Alginates[tiab] OR Hydrogel[tiab] OR Hydrogels[tiab] OR Silver OR Bead[tiab] OR Foam[tiab] OR Foams[tiab] OR non-adherent[tiab] OR \"non adherent\"[tiab] OR hydrocolloid[tiab] OR Hydrocolloids[tiab] OR Honey[tiab] OR Honeys[tiab] OR matrix[tiab] OR Collagenases[tiab] OR Collagenase[tiab]) AND (\"Pressure Ulcer\"[Mesh] OR \"Pressure ulcer\"[tiab] OR \"Pressure ulcers\"[tiab] OR Bedsore[tiab] OR Bedsores[tiab] OR \"Pressure Sore\"[tiab] OR \"Pressure Sores\"[tiab] OR \"Bed Sores\"[tiab] OR \"Bed Sore\"[tiab] OR \"Decubitus Ulcer\"[tiab] OR \"Decubitus Ulcers\"[tiab]) AND (\"Wound Healing\"[Mesh] OR \"Debridement\"[Mesh] OR Healing[tiab] OR Healings[tiab] OR \"Wound therapy\"[tiab] OR Debridement[tiab] OR Debridements[tiab] OR \"Wound treatment\"[tiab] OR Treating[tiab]) AND (randomized controlled trial[Publication Type] OR controlled clinical trial[Publication Type] OR randomized[Title/Abstract] OR randomised[Title/Abstract] OR placebo[Title/Abstract] OR \"drug therapy\"[MeSH Terms] OR randomly[Title/Abstract] OR trial[Title/Abstract] OR groups[Title/Abstract]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]/))", "generated_query": ["What is the effectiveness of bandages, alginates, hydrogels, silver, \"Silver Sulfadiazine\", honey, \"Collagenases\", and randomized controlled trials or controlled clinical trials in the treatment and management of pressure ulcers or decubitus ulcers, as well as their associated symptoms such as pain, edema, and infection?", "What is the effectiveness of bandages and dressings, including alginates, hydrogels, and silver, as well as honey and collagenases, in the diagnosis and treatment of pressure ulcers and wound healing, as evaluated in randomized controlled trials?", "What is the effectiveness of bandages, alginates, hydrogels, silver, and honey in the treatment of pressure ulcers, bedsores, and wounds? This includes randomized controlled trials or controlled clinical trials, as well as placebo or drug therapy, and does not involve animals.", "What is the effectiveness of bandages, alginates, hydrogels, silver, or honey in the treatment of pressure ulcers or wound healing? Are there any randomized controlled trials or controlled clinical trials that have investigated their efficacy?", "What is the effectiveness of bandages, alginates, hydrogels, silver, \"Silver Sulfadiazine\", honey, \"Collagenases\", and randomized controlled trials or controlled clinical trials in wound healing or debridement?", "What is the effectiveness of bandages, alginates, hydrogels, silver, or honey in healing pressure ulcers or wounds, as well as randomized controlled trials or controlled clinical trials, and what is the effectiveness of bandage or dressing materials in preventing or treating them?", "What is the effectiveness of bandages, alginates, hydrogels, silver, or honey in the treatment of pressure ulcers, bedsores, or decubitus ulcers, as well as randomized controlled trials or controlled clinical trials?", "What is the effectiveness of silver, alginates, hydrogels, or honey in the treatment of pressure ulcers, bedsores, or wounds? This includes randomized controlled trials or controlled clinical trials that have investigated their efficacy.", "What is the effectiveness of bandages, alginates, hydrogel, silver, or honey in the treatment of pressure ulcers or wound healing, as evaluated by randomized controlled trials or controlled clinical trials?", "What is the effectiveness of bandages, alginates, hydrogels, silver, or honey in the treatment of pressure ulcers or wounds, as well as randomized controlled trials or controlled clinical trials, and placebo or drug therapy, in patients with animals or humans?"]}
{"id": "46", "boolean": "(((\"Dementia\"[MeSH] OR Dementia[tiab] OR Dementias[tiab] OR Demented[tiab] OR \"Neurocognitive Disorders\"[tiab] OR \"Neurocognitive Disorder\"[tiab] OR \"Memory disorders\"[tiab] OR \"Memory disorder\"[tiab] OR \"Cognitive decline\"[tiab] OR \"cognitive disorders\"[tiab] OR Alzheimer[tiab] OR Alzheimers[tiab] OR alzheimer\u2019s[tiab])) OR (\"Caregivers\"[Mesh] OR Caregivers[tiab] OR Caregiver[tiab] OR Carer[tiab] OR Carers[tiab])) OR ((Cultural[tiab] OR Culturally[tiab]) AND Care[tiab]) AND (\"africa, northern\"[Mesh] OR \"northern africa\"[tiab] OR \"North africa\"[tiab] OR \"algeria\"[Mesh] OR \"algeria\"[tiab] OR \"egypt\"[Mesh] OR \"egypt\"[tiab] OR \"libya\"[Mesh] OR \"libya\"[tiab] OR \"morocco\"[Mesh] OR \"morocco\"[tiab] OR \"tunisia\"[Mesh] OR \"tunisia\"[tiab] OR \"sudan\"[Mesh] OR \"sudan\"[tiab] OR \"middle east\"[Mesh] OR \"middle east\"[tiab] OR \"bahrain\"[Mesh] OR \"bahrain\"[tiab] OR \"iraq\"[Mesh] OR \"iraq\"[tiab] OR \"jordan\"[Mesh] OR \"jordan\"[tiab] OR \"kuwait\"[Mesh] OR \"kuwait\"[tiab] OR \"lebanon\"[Mesh] OR \"lebanon\"[tiab] OR \"oman\"[Mesh] OR \"oman\"[tiab] OR \"qatar\"[Mesh] OR \"qatar\"[tiab] OR \"saudi arabia\"[Mesh] OR \"saudi arabia\"[tiab] OR \"syria\"[Mesh] OR \"syria\"[tiab] OR \"united arab emirates\"[Mesh] OR \"united arab emirates\"[tiab] OR \"yemen\"[Mesh] OR \"yemen\"[tiab] OR \"somalia\"[Mesh] OR \"somalia\"[tiab] OR \"mauritania\"[Mesh] OR \"mauritania\"[tiab] OR \"djibouti\"[Mesh] OR \"djibouti\"[tiab] OR \"arabs\"[Mesh] OR \"arabs\"[tiab] OR Arab[tiab] OR \"comoros\"[Mesh] OR \"comoros\"[tiab] OR lebanese[tiab] OR libanaise[tiab] OR \"aden\"[tiab] OR \"sanaa\"[tiab] OR UAE[tiab] OR \"abu dhabi\"[tiab] OR dubai[tiab] OR \"muscat\"[tiab] OR palestina[tiab] OR palestinae[tiab] OR palestine[tiab] OR palestinians[tiab] OR gaza[tiab] OR \"west bank\"[tiab] OR KSA[tiab] OR tunis[tiab] OR MENA[tiab] OR EMRO[tiab] OR \"arabia\"[Mesh] OR \"arabia\"[tiab] OR somali[tiab] OR \"mauritania\"[Mesh] OR \"mauritania\"[tiab] OR levant[tiab] OR Gulf[tiab] OR \"Arabian Gulf\"[tiab] OR \"persian gulf\"[tiab]) AND (\"Aging\"[Mesh] OR \"Aged\"[Mesh] OR \"Aging\"[tiab] OR Aged[tiab] OR \"Senility\"[tiab] OR \"old age\"[tiab] OR \"elderly\"[tiab] OR Older[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh])", "generated_query": ["What is the effectiveness of interventions for dementia, neurocognitive disorders, and related conditions, including Alzheimer's disease, that have been evaluated in randomized controlled trials or placebo-controlled studies?", "What are the effectiveness of dementia caregiver interventions, including randomized controlled trials and observational studies, in improving the quality of life for both caregivers and patients?", "What is the effectiveness of interventions for dementia, neurocognitive disorders, and memory disorders, including those related to Alzheimer's disease, as compared to placebo or other treatments, in preventing or treating cultural caregivers of the northern Africa region? This includes randomized controlled trials or controlled clinical trials, as well as epidemiologic studies or case-control studies.", "What is the effectiveness of interventions for dementia, neurocognitive disorders, memory disorders, and related conditions, including Alzheimer's disease and other related diseases, as compared to placebo or other treatments, in improving cognitive function and reducing the risk of dementia or neurocognitive disorders, as well as other related conditions? This includes randomized controlled trials or controlled clinical trials, as well as epidemiologic studies, case-control studies, cohort studies, and follow-up observations.", "What is the effectiveness of dementia caregivers, including those in Africa, Northern Africa, and the Middle East, in detecting and monitoring cognitive decline or Alzheimer's disease? This includes randomized controlled trials, controlled clinical trials, and epidemiologic studies.", "What is the effectiveness of caregivers in detecting cognitive impairment or dementia, as well as neurocognitive disorders, memory loss, and other related conditions, in elderly individuals? This includes randomized controlled trials, controlled clinical trials, and follow-up observation of elderly individuals.", "What are the most effective caregiving interventions for dementia, neurocognitive disorders, and related conditions, as evaluated in randomized controlled trials or controlled clinical trials? This includes interventions for elderly individuals, as well as those for people of any age with cognitive impairment or neurocognitive disorder, and includes the evaluation of epidemiologic studies, case-control studies, cohort studies, and follow-up observation?", "What are the effects of dementia and neurocognitive disorders, including Alzheimer's disease and Lewy body dementia, on the caregivers and cultural practices of Northern Africa, including Algeria, Egypt, and Sudan, as evaluated in randomized controlled trials or controlled clinical trials, and involving placebo or other treatments, in addition to the effects of epidemiology, case-control studies, and follow-up?", "What is the effectiveness of interventions for dementia, including caregivers, cultural, and educational programs, as compared to placebo or other treatments, in reducing symptoms of dementia, neurocognitive disorders, memory disorders, and cognitive decline, as evaluated in randomized controlled trials or controlled clinical trials?", "What are the most effective interventions for dementia, neurocognitive disorders, and related conditions, including Alzheimer's disease, as evaluated in randomized controlled trials or controlled clinical trials? This includes studies on the diagnosis and management of these conditions, as well as follow-up and observation of the interventions. Additionally, what are the most effective epidemiological studies and analysis of statistics and data on the diagnosis and management of these conditions?"]}
{"id": "42", "boolean": "( (\"Checklist\"[Mesh] OR \"Forms and Records Control\"[Mesh] OR Checklist[tiab] OR Checklists[tiab] OR Tool[tiab] OR Tools[tiab] OR Scale[tiab] OR Scales[tiab] OR Score[tiab] OR Scores[tiab] OR Scored[tiab]) AND (\"Research Design/methods\"[Mesh] OR \"Research Design/standards\"[Mesh] OR Valid[tiab] OR Validity[tiab] OR Quality[tiab] OR \"Critical appraisal\"[tiab] OR \"Critical review\"[tiab] OR Bias[tiab] OR Biased[tiab]) AND (Assess[tiab] OR Assessed[tiab] OR Assessing[tiab] OR Assessment[tiab] OR Measure[tiab] OR Measures[tiab] OR Measured[tiab] OR Evaluate[tiab] OR Evaluated[tiab] OR Evaluating[tiab]) AND (\"Meta-Analysis as Topic\"[Mesh] OR \"Review Literature as Topic\"[Mesh] OR \"Clinical Trials as Topic\"[Mesh] OR Study[tiab] OR Studies[tiab] OR Article[tiab] OR Articles[tiab] OR Meta-Analysis[tiab] OR \"Meta Analysis\"[tiab] OR Metaanalysis[tiab] OR Meta-analyses[tiab] OR \"Meta analyses\"[tiab] OR Metaanalyses[tiab]) AND (\"Methods\"[Mesh] OR Method[tiab] OR Methodological[tiab] OR Methodology[tiab] OR Methodologic[tiab]) AND (\"Reproducibility of Results\"[Mesh] OR \"Quality Control\"[Mesh] OR Reproducibility[tiab] OR Evidence[tiab] OR Reliability[tiab] OR Reliable[tiab] OR Index[tiab] OR Proxy[tiab]) ) AND ( (Scale[ti] OR Scales[ti] OR Checklist[ti] OR Checklists[ti] OR Tool[ti] OR Tools[ti] OR Instrument[ti] OR Instruments[ti] OR Technique[ti] OR Techniques[ti] OR Score[ti] OR Scored[ti] OR Quality[ti] OR Assess[ti] OR Assessed[ti] OR Assessing[ti] OR Assessment[ti] OR Evaluate[ti] OR Evaluated[ti] OR Evaluating[ti]) )", "generated_query": ["What are the most effective methods for research design and clinical trials, as well as the reproducibility and reliability of results, in order to evaluate the effectiveness of checklists, forms and records control, and other research tools?", "What is the effectiveness of checklists and forms and records control in research design and methods, clinical trials, and studies, as well as their associated meta-analyses and reviews, in the reproducibility of results and quality control of evidence?", "What is the checklist or form and records control system used in research design and methods, as well as clinical trials and studies, and how do they impact the quality and reliability of results? Additionally, what is the reproducibility and reliability of the tool or instruments used to gather data, as well as the techniques and indexes used to assess the results, and how do they compare to a meta-analysis of studies?", "What is the accuracy and reliability of research results and clinical trials, as well as the reproducibility of their results, when using checklists, forms and records control, and other tools or techniques to collect and process data?", "What is the effectiveness of checklists and forms and records control in the research design and methods of clinical trials, study, article, and meta-analysis, as well as the reproducibility of results and quality control, for the assessment and evaluation of research findings? Additionally, what is the accuracy and reliability of the tools and techniques used to conduct research, and how do they compare to placebo or other treatments, in reducing bias or distortion of results?", "What is the quality of research design and methods for conducting critical appraisal of studies, clinical trials, and research literature, and how do these methods impact the reliability and reproducibility of results? Additionally, what is the quality control and evidence for the accuracy and reliability of scales, checklists, tools, instruments, and techniques for assessing and evaluating the results of research studies? Finally, what is the meta-analysis of these studies and how do they impact the accuracy and reliability of the research findings?", "What is the accuracy and reliability of research results and methods, as evaluated by critical appraisal and meta-analysis, and documented by forms and records control?", "What is the accuracy and reliability of research design and methods for the assessment and diagnosis of clinical trials? Additionally, what is the quality and reproducibility of results, as evaluated through forms and records control, scaled scoring, and meta-analysis, and how do they compare to external indexes and proxies?", "What is the accuracy and reliability of research design and methods, including clinical trials and meta-analysis, for identifying and evaluating checklists, forms and records control, and other tools or instruments for the purpose of researching and designing studies, as well as for the reproducibility and reliability of results, and the quality and assessment of studies?", "What is the research design or methods for collecting and managing checklists, forms and records control, and other research materials in a valid and quality-assured manner? Additionally, what is the reproducibility of results and reliability of index or proxy values for the scale or score of the studies, and how do techniques or techniques improve the accuracy and efficiency of the research?"]}
{"id": "64", "boolean": "((\"Diabetes, Gestational\"[Mesh] OR \"Gestational diabetes\"[tiab] OR \"Pregnancy-Induced Diabetes\"[tiab] OR \"Pregnancy Induced Diabetes\"[tiab]) OR ((Overweight[tiab] OR Obese[tiab]) AND (Pregnant[tiab] OR Pregnancy[tiab])) ) AND (\"Metformin\"[Mesh] OR Metformin[tiab] OR Dimethylbiguanidine[tiab] OR Dimethylguanylguanidine[tiab] OR Glucophage[tiab]) AND (\"Pregnancy Complications\"[Mesh] OR Prevention[tiab] OR Preventing[tiab] OR Complication[tiab] OR Complications[tiab] OR Risk[tiab] OR \"androgen excess\"[tiab] OR hyperandrogenism[tiab] OR \"polycystic ovary syndrome\"[tiab] OR \"polycystic ovarian syndrome\"[tiab] OR \"polycystic ovarian disease\"[tiab] OR \"polycystic ovaries\"[tiab] OR PCOS[tiab] OR hirsutism[tiab] OR acne[tiab] OR alopecia[tiab] OR \"menstrual dysfunction\"[tiab] OR anovulation[tiab] OR infertility[tiab] OR subfertility[tiab] OR \"ovulation induction\"[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh])", "generated_query": ["What are the effectiveness of metformin, glucophage, and other related compounds in the prevention and management of diabetic complications, including increased androgen levels and polycystic ovary syndrome, as well as randomized controlled trials and case-control studies, and what is the statistical and numerical data behind these trials and studies?", "What is the effectiveness of metformin or glucophage in the prevention or management of diabetic complications, including gestational diabetes, pregnancy-induced diabetes, and high risk of androgen excess or hyperandrogenia, as well as other related conditions such as polycystic ovary syndrome or disease, and how do randomized controlled trials or cohort studies support these claims?", "What are the effectsiveness of metformin, dimethylbiguanidine, and glucophage in preventing or treating gestational diabetes or pregnancy-induced diabetes? This includes randomized controlled trials, controlled clinical trials, and epidemiologic studies.", "What is the effectiveness of metformin and related compounds (dimethylbiguanidine, diethylguanidine, and glucophage) in the prevention and management of gestational diabetes, pregnancy-induced diabetes, and related complications, including androgen excess and hyperandrogenia, as well as polycystic ovary syndrome and other related conditions, as evaluated in randomized controlled trials and follow-up studies?", "What is the effectiveness of metformin, glucophage, or dimethylbiguanidine/guanylguanidine in the prevention or treatment of gestational diabetes or pregnancy-induced diabetes, as well as related complications such as androgen excess, hyperandrogenism, polycystic ovary syndrome, or PCOS, and how do randomized controlled trials or controlled clinical trials confirm its efficacy?", "What is the effectiveness of metformin or other glucose-lowering medications in preventing gestational diabetes, as well as other pregnancy complications such as hypertension, macular degeneration, and neurological damage, as compared to placebo or other glucose-lowering medications, in reducing morbidity and mortality in both the mother and the baby? Additionally, are there any randomized controlled trials or observational studies that have investigated the effectiveness of metformin or other glucose-lowering medications in reducing morbidity and mortality in both the mother and the baby?", "What is the effectiveness of metformin, glucophage, or dimethylbiguanidine in preventing gestational diabetes or related complications such as androgen excess, hyperandrogenism, polycystic ovary syndrome, PCOS, hirsutism, acne, alopecia, and menstrual dysfunction? This includes randomized controlled trials, controlled clinical trials, and follow up studies.", "What are the most effective diabetic treatments for pregnancy complications, including but not limited to metformin, glucophage, and other related compounds, as compared to placebo or other treatments, in preventing or treating gestational diabetes or other related conditions? Additionally, what are the associated risks or benefits of these treatments, as evaluated in randomized controlled trials or follow-up studies, and how do they compare to each other in terms of their effectiveness?", "What is the effectiveness of metformin, glucophage, or dimethylbiguanidine in the prevention or management of diabetic complications, including PCOS, hirsutism, acne, alopecia, and menstrual dysfunction, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of metformin, glucophage, and other diabetic medications in preventing and treating gestational diabetes? This question is addressed in randomized controlled trials, controlled clinical trials, and epidemiologic studies."]}
{"id": "6", "boolean": "((\"Diabetes, Gestational\"[Mesh] OR \"Gestational diabetes\"[tiab] OR \"Pregnancy-Induced Diabetes\"[tiab] OR \"Pregnancy Induced Diabetes\"[tiab]) AND (\"Glyburide\"[Mesh] OR \"Acarbose\"[Mesh] OR \"Metformin\"[Mesh] OR \"Biguanides\"[Mesh] OR \"Sulfonylurea Compounds\"[Mesh] OR \"Thiazolidinediones\"[Mesh] OR \"Dipeptidyl-Peptidase IV Inhibitors\"[Mesh] OR \"Glycoside Hydrolase Inhibitors\"[Mesh] OR \"Sodium-Glucose Transporter 2 Inhibitors\"[Mesh] OR \"Insulin\"[Mesh] OR \"Glucagon-Like Peptide 1\"[Mesh] OR \"Exenatide\"[Mesh] OR \"Glipizide\"[Mesh] OR \"Insulin Lispro\"[Mesh] OR \"Isophane Insulin, Human\"[Mesh] OR \"Insulin, Isophane\"[Mesh] OR \"Insulin Glargine\"[Mesh] OR \"Insulins\"[Mesh] OR \"Xultophy\" [Supplementary Concept] OR \"Liraglutide\"[Mesh] OR \"Linagliptin\"[Mesh] OR \"repaglinide\" [Supplementary Concept] OR \"Sitagliptin Phosphate\"[Mesh] OR \"Sitagliptin Phosphate, Metformin Hydrochloride Drug Combination\"[Mesh] OR \"empagliflozin\" [Supplementary Concept] OR \"dulaglutide\" [Supplementary Concept] OR Glyburide[tiab] OR Glybenclamide[tiab] OR Glibenclamide[tiab] OR Diabeta[tiab] OR \"Euglucon 5\"[tiab] OR Neogluconin[tiab] OR HB-419[tiab] OR \"HB 419\"[tiab] OR HB419[tiab] OR HB-420[tiab] OR \"HB 420\"[tiab] OR HB420[tiab] OR Maninil[tiab] OR Micronase[tiab] OR Daonil[tiab] OR \"Euglucon N\"[tiab] OR \"Acarbose\"[tiab] OR Glumida[tiab] OR Glucobay[tiab] OR Glucor[tiab] OR \"Bay g 5421\"[tiab] OR Prandase[tiab] OR Precose[tiab] OR \"Metformin\"[tiab] OR Dimethylbiguanidine[tiab] OR Dimethylguanylguanidine[tiab] OR Glucophage[tiab] OR biguanides[tiab] OR sulfonylureas[tiab] OR meglitinides[tiab] OR thiazolidinediones[tiab] OR \"dipeptidyl peptidase IV inhibitors\"[tiab] OR \"DPP-IV inhibitors\"[tiab] OR \"\u03b1-glucosidase inhibitors\"[tiab] OR \"SGLT2 inhibitors\"[tiab] OR gliflozins[tiab] OR Insulin[tiab] OR \"Glucagon like peptide\u20131\"[tiab] OR \"GLP-1 agonists\"[tiab] OR Amylinomimetics[tiab] OR Exenatide[tiab] OR Glicalzide[tiab] OR Glimepride[tiab] OR Glipizide[tiab] OR Mixtard[tiab] OR Actrapid[tiab] OR Humalog[tiab] OR Insulatard[tiab] OR Isophane[tiab] OR Glargine[tiab] OR \"Levemir Detemir\"[tiab] OR \"Degludec pen\"[tiab] OR \"Novomix pen\"[tiab] OR \"Novoraid vial\"[tiab] OR \"Saxenda liraglutide\"[tiab] OR Linagliptin[tiab] OR Dapagliflozin[tiab] OR Piogitazine[tiab] OR Repaglinide[tiab] OR \"Galvus met\"[tiab] OR Vidagliptin[tiab] OR Sitagliptin[tiab] OR Janumet[tiab] OR Empagliflozin[tiab] OR Dulaglutide[tiab]) AND (\"Therapeutic use\"[sh] OR Therapeutic[tiab] OR Therapy[tiab] OR Therapies[tiab]) AND (Effect[tiab] OR Effects[tiab] OR Impact[tiab] OR Modify[tiab] OR Decrease[tiab] OR Decreases[tiab] OR Declined[tiab] OR Declines[tiab] OR Reduce[tiab] OR Reducing[tiab] OR Reduces[tiab] OR Reduction[tiab] OR Differences[tiab] OR Difference[tiab] OR Different[tiab] OR Comparing[tiab] OR Versus[tiab]) AND (\"Female\"[Mesh] OR Female[tiab] OR Females[tiab] OR Women[tiab] OR Woman[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])))", "generated_query": ["What is the effectiveness of diabetic interventions involving glyburide, acarbose, metformin, and other related compounds in the treatment of gestational diabetes? Additionally, what are the therapeutic impacts of these interventions, as evaluated in randomized controlled trials or controlled clinical trials, on the diabetic condition in humans?", "What is the effectiveness of diabetes medicines, including glucagon-like peptide-1 and other hormones, in treating gestational diabetes or pregnancy-induced diabetes? Additionally, what is the impact of these medicines on reducing morbidity and mortality in both mother and child?", "What is the effectiveness of diabetic interventions, including those related to gestational diabetes, that are therapeutic or have impact on the development or progression of the disease, as evaluated by randomized controlled trials or controlled clinical trials, in which placebo or drug therapy is compared to animals not human?", "What is the effectiveness of diabetes medicines, including glyburide, acarbose, metformin, and SGLT2 inhibitors, in the treatment of gestational diabetes or pregnancy-induced diabetes? Additionally, do these medicines have any impact on the development or progression of diabetes, as well as its complications, in both females and humans? Finally, what are the results of randomized controlled trials or controlled clinical trials that have investigated their efficacy?", "What is the effectiveness of diabetic treatments involving glyburide, acarbose, metformin, and other compounds to reduce glucose levels and improve glycemic control in both men and women, as evaluated in randomized controlled trials?", "What is the effectiveness of diabetes medicines, including glyburide, acarbose, metformin, biguanides, sulfonylureas, and thiazolidinediones, in the treatment and management of pregnancy-induced diabetes or gestational diabetes?", "What is the effectiveness of diabetes therapies, including glyburide, acarbose, metformin, and other Biguanides or Sulfonylureas, as compared to placebo or randomized controlled trials, in reducing HbA1c levels or complications of diabetes, particularly in women?", "What is the effectiveness of diabetes medicines, including Glyburide, Acarbose, Metformin, Biguanides, Sulfonylurea Compounds, Thiazolidinediones, and DPPIV inhibitors, in the treatment of pregnancy-induced diabetes? Additionally, what are the clinical trials or randomized controlled trials that have investigated their efficacy?", "What is the effectiveness of diabetic medicines, including glyburide, acarbose, metformin, and thiazolidinediones, in the treatment of gestational diabetes?", "What is the effectiveness of diabetes medications, including Glyburide, Acarbose, Metformin, Biguanides, Sulfonylurea Compounds, Thiazolidinediones, Dipeptidyl-Peptidase IV Inhibitors, Glycoside Hydrolase Inhibitors, Sodium-Glucose Transporter 2 Inhibitors, Insulin, Glycogen, and Glucagon-Like Peptide 1, as well as other compounds such as Exenatide, Glipizide, Isophane, and Glicobay, in the treatment of diabetes mellitus? Additionally, what are the therapeutic and randomized controlled trials or controlled clinical trials that have investigated their efficacy? Finally, what is the impact of these medications on females, including those who are randomized or trialed, and how do they compare to placebo or other treatments in reducing complications or differences, as well as enhancing metabolism and glucose transport?"]}
{"id": "7", "boolean": "(\"Life Style\"[Mesh] OR \"Diet\"[Mesh] OR \"Exercise\"[Mesh] OR \"Patient Education as Topic\"[Mesh] OR \"Life Style\"[tiab] OR Lifestyle[tiab] OR Exercise[tiab] OR Counseling[tiab] OR Dietary[tiab] OR Dieting[tiab] OR Educational[tiab] OR \"Patient education\"[tiab] OR \"Eating habits\"[tiab] OR \"Eating patterns\"[tiab] OR \"Weight measurement\"[tiab]) AND (\"Pregnancy Outcome\"[Mesh] OR \"Pregnancy Complications\"[Mesh] OR \"Birth weight\"[Mesh] OR \"Pregnancy Outcome\"[tiab] OR \"Pregnancy Outcomes\"[tiab] OR \"Pregnancy Complications\"[tiab] OR \"Pregnancy Complication\"[tiab] OR ((Pregnancy[Mesh] OR Pregnancy[tiab] OR Gestational[tiab]) AND (\"Weight Gain\"[Mesh] OR \"Weight gain\"[tiab] OR \"Glucose metabolism\"[tiab]))) AND (\"Treatment Outcome\"[Mesh] OR Effect[tiab] OR Effects[tiab] OR Impact[tiab] OR Modify[tiab] OR Decrease[tiab] OR Decreases[tiab] OR Declined[tiab] OR Declines[tiab] OR Reduce[tiab] OR Reducing[tiab] OR Reduces[tiab] OR Reduction[tiab] OR Change[tiab] OR Changes[tiab] OR Differences[tiab] OR Difference[tiab] OR Different[tiab]) AND (\"Risk Reduction Behavior\"[Mesh] OR \"Primary Prevention\"[Mesh] OR \"prevention and control\"[sh] OR Prevent[tiab] OR Prevents[tiab] OR Preventing[tiab] OR Unfavorable[tiab] OR Adverse[tiab] OR Retention[tiab] OR Activity[tiab] OR Capacity[tiab] OR Negative[tiab] OR Restrict[tiab] OR Restricted[tiab] OR Adherence[tiab] OR Assess[tiab] OR Assessed[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (\"Case Reports\"[pt] OR Editorial[pt] OR Letter[pt] OR Meta-Analysis[pt] OR \"Observational Study\"[pt] OR \"Systematic Review\"[pt] OR \"Case Report\"[ti] OR \"Case series\"[ti] OR Meta-Analysis[ti] OR \"Meta Analysis\"[ti] OR \"Systematic Review\"[ti]) AND (\"Life Style\"[ti] OR Lifestyle[ti] OR Exercise[ti] OR Counseling[ti] OR Diet[ti] OR Dietary[ti] OR Dieting[ti] OR Educational[ti] OR \"Patient education\"[ti] OR \"Eating habits\"[ti] OR \"Eating patterns\"[ti] OR \"Weight measurement\"[ti] OR Pregnant[ti] OR \"Pregnancy Outcome\"[ti] OR \"Pregnancy Outcomes\"[ti] OR \"Pregnancy Complications\"[ti] OR \"Pregnancy Complication\"[ti] OR Pregnancy[ti] OR Gestational[ti] OR \"Weight gain\"[ti] OR \"Glucose metabolism\"[ti])", "generated_query": ["What is the effectiveness of patient education and lifestyle modifications, including diet and exercise, in reducing risk for adverse pregnancy outcomes and complications, as well as birth weight, in patients with increased glucose metabolism? This question can be investigated through randomized controlled trials or placebo-controlled studies, as well as case reports or editorials, and should also include assessment of dietary intake and exercise habits, as well as weight measurement and pregnancy outcome.", "What is the effectiveness of patient education, diet, exercise, and randomized controlled trials or controlled clinical trials in improving pregnancy outcome, including birth weight, and preventing or treating complications such as gestational weight gain and glucose metabolism?", "What is the effectiveness of patient education and treatment outcome interventions, including randomized controlled trials and systematic reviews, for the prevention and management of pregnancy outcome, complications, and birth weight, as well as randomized controlled trials and systematic reviews, for the reduction of risk behavior, primary prevention, and adherence to interventions? This includes interventions for weight gain and glucose metabolism, as well as animal and human case reports and meta-analyses, and educational, counseling, and dietary interventions.", "What is the impact of patient education, exercise, and dietary interventions on the outcome and complications of pregnancy, including birth weight and glucose metabolism, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the impact of patient education, exercise, and dietary interventions on the outcome of pregnancy, including birth weight, gestational diabetes, and glucose metabolism, as evaluated by randomized controlled trials and editorial reviews?", "What is the effectiveness of patient education and lifestyle interventions in preventing pregnancy complications, including birth weight, and improving glucose metabolism in patients at risk for developing diabetes? Randomized controlled trials or controlled clinical trials are needed to assess the effectiveness of these treatments.", "What is the effectiveness of patient education and life style interventions in improving pregnancy outcome and risk reduction behavior, as evaluated in randomized controlled trials or controlled clinical trials, and involving placebo or drug therapy, as well as case reports, editorials, and systematic reviews, for reducing gestational weight gain and glucose metabolism?", "What is the effectiveness of patient education, exercise, and dietary interventions in improving pregnancy outcome and preventing complications, including birth weight, glucose metabolism, and weight gain, as evaluated in randomized controlled trials or controlled clinical trials, and involving animals or humans?", "What is the effectiveness of patient education, exercise, and nutrition interventions in improving pregnancy outcome and reducing risk of complications, including birth weight, glucose metabolism, and weight gain, as evaluated in randomized controlled trials or placebo-controlled studies?", "What is the effectiveness of patient education and lifestyle interventions, including diet, exercise, and counseling, in reducing risk and improving pregnancy outcomes, including birth weight, glucose metabolism, and other risk markers, as evaluated in randomized controlled trials or controlled clinical trials, in conjunction with weight gain or glucose metabolism?"]}
{"id": "67", "boolean": "(((\"Diabetes, Gestational\"[Mesh] OR Diabetes[tiab]) AND (\"Pregnancy\"[Mesh] OR Pregnancy[tiab] OR Pregnant[tiab] OR Pregnancies[tiab] OR Gestation[tiab] OR Gestational[tiab])) OR ((\"Pregnancy\"[Mesh] OR Pregnancy[tiab] OR Pregnant[tiab] OR Pregnancies[tiab] OR Gestation[tiab] OR Gestational[tiab]) AND (\"Obesity\"[Mesh] OR Obesity[tiab] OR Obese[tiab]))) AND (\"Life Style\"[Mesh] OR \"Insulin\"[Mesh] OR Metformin[Mesh] OR \"Life Style Intervention\"[tiab] OR \"Lifestyle Intervention\"[tiab] OR \"Exercise intervention\"[tiab] OR Metformin[tiab] OR \"Insulin sensitising\"[tiab] OR \"Lifestyle counseling\"[tiab] OR \"Glucose tolerance\"[tiab] OR \"Antenatal care \"[tiab] OR \"Dietary management\"[tiab]) AND (\"Treatment Outcome\"[Mesh] OR \"Pregnancy Outcome\"[Mesh] OR \"Pregnancy Complications\"[Mesh] OR \"Morbidity\"[Mesh] OR Prevention[tiab] OR Prevent[tiab] OR Preventing[tiab] OR \"Insulin resistance\"[tiab] OR Incidence[tiab] OR Prevalence[tiab] OR ((Improved[tiab] OR Adverse[tiab] OR Obstetric[tiab] OR Pregnancy[tiab]) AND (Outcome[tiab] OR Outcomes[tiab]))) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What are the benefits and outcomes of diabetic interventions, including insulin, metformin, and lifestyle counseling, for improving the health and well-being of pregnant women?", "What is the effectiveness of diabetic interventions, including insulin, metformin, and lifestyle counseling, in reducing morbidity and preventing complications in pregnancy? Additionally, what are the outcome and treatment effectiveness of randomized controlled trials or controlled clinical trials in improving diabetic management? Finally, what is the effectiveness of diabetic interventions in reducing randomized controlled trials or controlled clinical trials, as compared to placebo or drug therapy, in improving diabetic management?", "What is the effectiveness of lifestyle interventions, including dietary management, exercise, and metformin or insulin sensitizing, for the treatment and prevention of diabetes in pregnancy? Randomized controlled trials or controlled clinical trials have investigated their outcomes, including pregnancy outcome, complications, morbidity, and incidence, as well as glucose tolerance and insulin resistance, and have found them to be beneficial.", "What is the effectiveness of life style interventions, including diabetes management with insulin or metformin, and randomized controlled trials or controlled clinical trials, for preventing gestational diabetes or obesity, and the related complications, including morbidity and mortality, as compared to placebo or drug therapy, in humans?", "What is the effectiveness of diabetes treatment interventions, including insulin, metformin, and exercise, in reducing morbidity and mortality in pregnancy?", "What is the effectiveness of diabetic pregnancy interventions, including life style, dietary management, and exercise, as compared to placebo or other treatments, in improving outcomes and preventing complications, morbidity, and mortality in both mother and baby? This question can be answered by randomized controlled trials or controlled clinical trials, in which both animals and humans are included, and in which outcome and complication-related information is collected.", "What is the effectiveness of diabetic interventions, including exercise, metformin, and lifestyle counseling, in improving pregnancy outcomes and preventing complications such as maculopathy, neurodevelopmental defects, and chromosomal abnormalities in the offspring of diabetic mothers?", "What are the most effective diabetic interventions for improving the outcome of pregnancy, including exercise and metformin, as compared to placebo or other treatments, as evaluated in randomized controlled trials or controlled clinical trials? Additionally, what is the impact of diabetic interventions on pregnancy complications, morbidity, and mortality, as well as glucose tolerance and sensitivity, and randomized controlled trials or controlled clinical trials?", "What is the effectiveness of lifestyle interventions and diabetes medications, including insulin, metformin, and exercise, in preventing or treating gestational diabetes? Randomized controlled trials or controlled clinical trials have investigated their outcomes, including pregnancy outcome, complications, morbidity, and prevention, as well as improved or adverse effects of interventions, and have concluded that lifestyle counseling and glucose tolerance are key factors in the management of diabetes during pregnancy.", "What is the effectiveness of diabetic interventions, including insulin or metformin therapy, in preventing or treating gestational diabetes? This includes randomized controlled trials or controlled clinical trials, as well as placebo or drug therapy, and not animals."]}
{"id": "44", "boolean": "(\"Acne Vulgaris\"[Mesh] OR Acne[tiab] OR Blackheads[tiab] OR Whiteheads[tiab] OR Pimples[tiab]) AND (\"Phototherapy\"[Mesh] OR \"Blue light\"[tiab] OR Phototherapy[tiab] OR Phototherapies[tiab] OR \"Photoradiation therapy\"[tiab] OR \"Photoradiation Therapies\"[tiab] OR \"Light Therapy\"[tiab] OR \"Light Therapies\"[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What are the most effective treatments for acne vulgaris, including phototherapy, blue light, and other light therapies, as compared to placebo or drug therapy, for improving skin complexion?", "What is the effectiveness of phototherapy or blue light therapy in the treatment of acne vulgaris or pimples, as well as blackheads and whiteheads, and randomized controlled trials or controlled clinical trials?", "What is the effectiveness of phototherapy or blue light therapy in treating acne vulgaris or acne pimples? This includes randomized controlled trials or controlled clinical trials that have investigated the efficacy of phototherapy or blue light therapy in treating acne, as well as those studies that have used placebo or drug therapy in their research. Additionally, studies that have used animals or humans in their research should be excluded.", "What are the most effective treatments for acne vulgaris, including phototherapy, blue light, and light therapy, as compared to drug therapy or randomized controlled trials or controlled clinical trials, for reducing inflammation and bacteria?", "What is the effectiveness of phototherapy, blue light, or other light therapies in treating acne vulgaris or acne, blackheads, whiteheads, pimples, and randomized controlled trials or controlled clinical trials?", "What is the effectiveness of phototherapy (blue light or other forms of light therapy) in the treatment of acne vulgaris or acne, as well as blackheads, whiteheads, pimples, and other related conditions? Are there any randomized controlled trials or controlled clinical trials that have investigated the efficacy of phototherapy?", "What is the effectiveness of phototherapy, including blue light and other wavelengths, in the treatment of acne vulgaris? Are there any randomized controlled trials or controlled clinical trials that have investigated its efficacy?", "What are the most effective treatments for acne vulgaris, including phototherapy and drug therapy, as compared to placebo or other treatments, for the randomized controlled trials or controlled clinical trials of light therapy or other treatments for acne?", "What is the effectiveness of phototherapy, including blue light, for the treatment of acne vulgaris or pimples, as well as blackheads and whiteheads, in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of phototherapy (blue light or other wavelengths) in the treatment of acne vulgaris, including acne, blackheads, whiteheads, pimples, and randomized controlled trials or controlled clinical trials?"]}
{"id": "105", "boolean": "(\"Lower Urinary Tract Symptoms\"[Mesh] OR \"Prostatic Hyperplasia\"[Mesh] OR \"Urinary tract symptoms\"[tiab] OR LUTS[tiab] OR Dysuria[tiab] OR Nocturia[tiab] OR Prostatism[tiab] OR \"Overactive bladder\"[tiab] OR \"Underactive bladder\"[tiab] OR \"Urinary Incontinence\"[tiab] OR \"Urinary Stress\"[tiab] OR \"Urinary Urge\"[tiab] OR \"Painful Urination\"[tiab] OR \"Frequent Urination\"[tiab] OR Nycturia[tiab] OR \"Urge Incontinence\"[tiab] OR \"Prostatic Hypertrophy\"[tiab] OR \"Prostatic Hyperplasia\"[tiab] OR \"Prostatic Adenomas\"[tiab] OR \"Prostatic Adenoma\"[tiab]) AND ( \"Self Care\"[Mesh] OR \"Behavior Therapy\"[Mesh] OR \"Life Style\"[Mesh] OR \"Self care\"[tiab] OR \"Self management\"[tiab] OR Self-management[tiab] OR SMP[tiab] OR Behavioral[tiab] OR Behavioural[tiab] OR \"Education\"[tiab] OR \"Fluid management\"[tiab] OR \"Bladder retraining\"[tiab] OR \"Bladder re-training\"[tiab] OR \"Toileting\"[tiab] OR \"Toilet training\"[tiab] OR \"Fluid input\"[tiab] OR \"Fluid manipulation\"[tiab] OR Lifestyle[ti] OR \"Life style\"[ti] OR Lifestyles[ti] OR \"Life styles\"[ti] OR ((Avoid[tiab] OR Avoiding[tiab]) AND (Constipation[tiab])) OR ((\"Fluid intake\"[tiab]) AND (Increase[tiab] OR Increasing[tiab] OR Decrease[tiab] OR Decreasing[tiab] OR Modify[tiab] OR Modifying[tiab])) OR ((\"Pelvic floor\"[tiab]) AND (training[tiab] OR exercise[tiab] OR exercises[tiab])) ) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (Female[Mesh] not (female[Mesh] and male[Mesh]))", "generated_query": ["What are the most effective treatments for lower urinary tract symptoms, including prostatic hyperplasia, urinary tract symptoms, and behavioral therapy, as evaluated in randomized controlled trials or controlled clinical trials? This includes the following conditions: nocturia, urge incontinence, painful urination, frequent urination, Nycturia, underactive bladder, and SMP.", "What are the most effective treatments for lower urinary tract symptoms, including prostatic hyperplasia, urinary tract symptoms, and behavior therapy, as evaluated in randomized controlled trials or controlled clinical trials? Specifically, I am interested in studies that do not involve animals or females.", "What are the most effective treatments for lower urinary tract symptoms, including prostatic hypertrophy and adenoma, as well as other related conditions such as incontinence, urge, pain, and frequency? This includes randomized controlled trials or controlled clinical trials that have investigated the effectiveness of self-care, behavior therapy, life style, and pelvic floor training. Additionally, what are the benefits of these treatments compared to placebo or drug therapy, and how do they compare to other treatments such as animals and humans, as well as female and male individuals?", "What is the effectiveness of self-care, behavior therapy, and life style interventions for lower urinary tract symptoms, prostatic hyperplasia, urinary tract symptoms, LUTS, Dysuria, Nocturia, Prostatism, Overactive bladder, Underactive bladder, Urinary Incontinence, Urethral Stress, and Painful Urination, as well as randomized controlled trials and controlled clinical trials, and the associated symptoms such as constipation, fluid intake, pelvic floor training, and exercise?", "What is the effectiveness of self-care, behavior therapy, life style, and randomized controlled trials or controlled clinical trials in the treatment of lower urinary tract symptoms, prostatic hyperplasia, urinary tract symptoms, LUTS, Dysuria, Nocturia, Prostatism, Overactive bladder, Underactive bladder, Urinary Incontinence, SMP, and behavioral therapy?", "What is the effectiveness of self care and behavior therapy in the management of lower urinary tract symptoms, including prostatic hyperplasia and urinary tract symptoms, as well as related conditions such as dysuria, nocturia, and prostatism? Randomized controlled trials or controlled clinical trials have investigated the efficacy of self care and behavior therapy, as well as fluid management and pelvic floor training, in the context of a healthy lifestyle and adequate fluid intake.", "What is the effectiveness of self care, behavior therapy, life style, and randomized controlled trials or controlled clinical trials in the diagnosis and management of lower urinary tract symptoms, prostatic hyperplasia, urinary tract symptoms, LUTS, dysuria, nocturia, and prostatism? Additionally, what is the effectiveness of fluid management and pelvic floor training in the diagnosis and management of lower urinary tract symptoms, prostatic hyperplasia, urinary tract symptoms, LUTS, dysuria, nocturia, and prostatism?", "What are the most effective treatments for lower urinary tract symptoms, including prostatic hyperplasia, urinary tract symptoms, LUTS, Dysuria, Nocturia, Prostatism, and bladder retraining, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of self care and behavior therapy interventions for lower urinary tract symptoms, including LUTS, dysuria, nocturia, and prostatism, as compared to placebo or drug therapy, in reducing symptoms and improving quality of life? This is evaluated in randomized controlled trials or controlled clinical trials. Additionally, does fluid management, including fluid intake and toileting, affect the outcome? Finally, does pelvic floor training or exercise affect the outcome?", "What is the effectiveness of self-care and behavior therapy in improving lower urinary tract symptoms and prostatic hyperplasia, as well as other related conditions such as LUTS, dysuria, nocturia, prostatism, overactive bladder, underactive bladder, urinary incontinence, urinary stress, urinary urge, and painful urination, as well as randomized controlled trials or controlled clinical trials, and drug therapy or placebo interventions, in animals and female humans?"]}
{"id": "12", "boolean": "(\"Urinary Tract Infections\"[Mesh] OR \"Cystitis\"[Mesh] OR \"Bacteriuria\"[Mesh] OR \"Urinary Tract Infections\"[tiab] OR \"Urinary Tract Infection\"[tiab] OR UTIs[tiab] OR UTI[tiab] OR Cystitis[tiab] OR Bacteriuria[tiab]) AND (\"Methenamine hippurate\"[Supplementary Concept] OR \"Methenamine\"[Mesh] OR \"Hippurates\"[Mesh] OR Hexamine[tiab] OR Hippurate[tiab] OR Hippurates[tiab] OR Urex[tiab] OR Hiprex[tiab] OR Hip-Rex[tiab] OR Urotractan[tiab] OR Hexamethylenetetramine[tiab] OR Methenamine[tiab] OR Urotropin[tiab] OR Aminoform[tiab] OR \"Hippuric acid\"[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR \"therapeutic use\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What is the effectiveness of methenamine hippurate or methenamine, or related compounds such as hexamine or hiprex, or urex, or hip-rex, or urotractan, or hippurate, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or hip-hurate, or urex, or h", "What is the effectiveness of methenamine hippurate or other compounds related to methenamine, such as hexamine or hippurate, in the treatment of urinary tract infections or cystitis? This question should be answered by randomized controlled trials or controlled clinical trials, and the results should be evaluated in both animals and humans.", "What is the effectiveness of methenamine hippurate, cystitis, bacteriuria, urinary tract infections, and related symptoms in humans?", "What is the effectiveness of methenamine hippurate or other drug therapies in the treatment of urinary tract infections or cystitis?", "What is the effectiveness of methenamine hippurate or hexamine in the treatment of urinary tract infections or cystitis, as well as bacteriuria or urinary tract infections, as compared to placebo or drug therapy, in reducing morbidity and mortality in both humans and animals?", "What is the effectiveness of methenamine hippurate or other related compounds in the treatment of urinary tract infections or cystitis, as well as bacteriuria and other related conditions, in conjunction with randomized controlled trials or controlled clinical trials?", "What is the effectiveness of methenamine hippurate or other drug therapies in treating urinary tract infections or cystitis, as well as bacteriuria and urinary tract infections, and how do they compare to placebo or randomized controlled trials or controlled clinical trials in humans or animals?", "What is the effectiveness of methenamine hippurate or other compounds related to it, including Hexamine, Urex, Hiprex, Hip-Rex, Urotractan, Hexamethylenetramine, Methenamine, Urotropin, Aminoform, and Hippuric acid, in the treatment of urinary tract infections or cystitis?", "What is the effectiveness of methenamine hippurate or other urinary tract infection treatments in reducing morbidity and mortality in both animals and humans, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of methenamine hippurate or other urinary tract infection medicines in treating urinary tract infections or cystitis, as well as bacteriuria or urinary tract infections, and how do these medicines compare to placebo or other treatments, including animals or humans, in randomized controlled trials or controlled clinical trials?"]}
{"id": "2", "boolean": "(\"Prognosis\"[Mesh] OR \"Natural history\"[tiab] OR \"Natural course\"[tiab] OR \"Clinical course\"[tiab] OR \"Watchful waiting\"[tiab] OR ((Symptom[tiab] OR Symptoms[tiab]) AND (Duration[tiab])) OR \"Wait and see\"[tiab] OR \"Active monitoring\"[tiab] OR Prognosis[tiab]) AND (Communication[tiab] OR Communicate[tiab] OR Framing[tiab] OR Discuss[tiab] OR \"Shared decision making\"[tiab] OR Presented[tiab] OR Perceptions[tiab] OR Perceive[tiab] OR Perceived[tiab]) AND (\"Decision Support Techniques\"[Mesh] OR \"Decision Making\"[Mesh] OR \"Decision Making, Shared\"[Mesh] OR \"Decision aid\"[tiab] OR \"Decision tool\"[tiab] OR Decision[tiab] OR Decisions[tiab]) AND (Graph[tiab] OR Graphs[tiab] OR Graphic[tiab] OR Graphics[tiab] OR Graphical[tiab] OR Chart[tiab])", "generated_query": ["What is the effectiveness of communication and decision support techniques in prognosing and diagnosing natural history, natural course, clinical course, watchful waiting, and shared decision making? This includes the presentation of information, perceptions, and decision making, as well as the use of graphic or visual aids.", "What is the effectiveness of communication and decision-making techniques that utilize graphic or visual displays to convey prognosis or natural history, as well as symptoms and duration, to patients and healthcare professionals?", "What is the effectiveness of decision support techniques and communication techniques, including graphics and charts, in prognosis, natural history, natural course, clinical course, watchful waiting, and symptom duration?", "What is the effectiveness of decision support techniques, including graphs or charts, in improving communication, framing, discussions, and shared decision making in prognosis or natural history, as well as clinical and watchful waiting, with patients about their symptoms and the duration of their symptoms?", "What is the effectiveness of decision support techniques and communication strategies in helping patients and doctors make prognosis-based decisions, including those related to natural history, clinical course, and watchful waiting, as well as symptom duration and shared decision making, and how do they compare to placebo or other treatments, as evaluated through the use of graphs or charts?", "What is the effectiveness of communication and decision support techniques for predicting the progression and clinical course of a disease, as well as the natural history and natural course of a given condition? Specifically, how do decision tools and graphical representations of data help patients and their doctors to better understand and make decisions about the treatment and management of their symptoms?", "What is the effectiveness of prognosis and natural history in the diagnosis and management of cancer, including the communication and decision-making techniques associated with them, as compared to other clinical course and watchful waiting options, as well as the symptoms and duration of those symptoms, and the decision support techniques and graphical visualizations of those decisions, for the treatment and management of cancer?", "What is the effectiveness of decision support techniques, including graphical depictions of prognosis and clinical course, in communicating and framing decisions to patients with symptoms suggestive of cancer, as well as their families and healthcare professionals, and in helping them to make informed decisions?", "What is the effectiveness of communication and decision support techniques in the diagnosis and prognosis of symptoms or conditions related to mental health? Specifically, how do these techniques impact the clinical course or duration of symptoms or conditions, as well as the prognosis or natural history, of individuals in the context of their shared decision making, and how do they help to create and sustain a positive clinical relationship between providers and patients? Additionally, how do these techniques help to provide and present decision-making aids or tools, as well as perceptions and perspectives, to patients?", "What are the communication and decision-making techniques that can help patients and healthcare providers understand and predict the natural history, clinical course, and prognosis of a disease, including symptoms and duration, as well as decision support techniques and graphics, to reach shared decision making and improve patient care?"]}
{"id": "3", "boolean": "(\"Copper\"[Mesh] OR Copper[tiab]) AND (\"Infections\"[Mesh] OR \"Equipment Contamination\"[Mesh] OR \"Infection Control\"[Mesh] OR \"Cross Infection\"[Mesh] OR Infection[tiab] OR Infections[tiab] OR Colonization[tiab]) AND (\"Health Facilities\"[Mesh] OR Hospital[tiab] OR Hospitals[tiab] OR \"Healthcare facility\"[tiab] OR \"Healthcare facilities\"[tiab] OR  \"Intensive care\"[tiab] OR \"Intensive-care\"[tiab] OR ICU[tiab] OR PICU[tiab] OR Ward[tiab] OR Wards[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR Control[tiab] OR Controlled[tiab] OR Comparing[tiab] OR Compared[tiab]) NOT  (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (\"Case Reports\"[pt] OR Editorial[pt] OR Letter[pt] OR \"Comment\"[pt] OR Meta-Analysis[pt] OR \"Observational Study\"[pt] OR \"Systematic Review\"[pt] OR \"Case Report\"[ti] OR \"Case series\"[ti] OR Meta-Analysis[ti] OR \"Meta Analysis\"[ti] OR \"Systematic Review\"[ti])", "generated_query": ["What is the effectiveness of copper-based equipment and materials in preventing infections or colonization in healthcare facilities, including hospitals and ICUs, as compared to placebo or other drugs, in reducing morbidity and mortality in both animals and humans? This includes randomized controlled trials or controlled clinical trials, as well as case reports and editorial comments.", "What is the effectiveness of copper-based antibiotics in the treatment and management of infections in healthcare facilities, including hospitals, intensive care units, and wards, as compared to placebo or other antibiotics, in reducing morbidity and mortality in both children and adults?", "What is the effectiveness of copper-based infection control in healthcare facilities, including hospitals and intensive care units, as compared to placebo or drug therapy, in preventing or treating infections, equipment contamination, infection control, or cross infection? This includes randomized controlled trials or controlled clinical trials, as well as case reports, editorials, letters, comments, or systematic reviews.", "What is the effectiveness of copper in preventing infections or equipment contamination, as well as infection control, cross infections, or randomized controlled trials or controlled clinical trials?", "What is the effectiveness of copper-based materials and equipment in preventing infections and equipment contamination in healthcare facilities, including randomized controlled trials and controlled clinical trials, and how do they compare to placebo or other treatments, such as drugs, in reducing morbidity and mortality in patients with infections?", "What is the effectiveness of copper-based interventions for the prevention of healthcare-associated infections, including antibiotics and vaccines, in comparison to placebo or other treatments, in reducing morbidity and mortality in both patients and healthcare workers?", "What is the effectiveness of copper-based infection control or equipment contamination prevention, as compared to placebo or other drug therapy, in reducing infections or colonization in healthcare facilities, including randomized controlled trials or controlled clinical trials, and how do case reports or editorials comment on the efficacy of copper-based interventions?", "What is the effectiveness of copper-based equipment and devices in the prevention and treatment of infections, including those related to HAIs, as well as the colonization and infestation of intensive care units and wards, as compared to placebo or drug therapy, in reducing morbidity and mortality in both humans and animals? This is the subject of a randomized controlled trial or controlled clinical trial, as well as a meta-analysis and systematic review of case reports, editorials, letters, comments, and meta-analyses, in addition to an observational study and a systematic review?", "What is the effectiveness of copper-based interventions for the prevention of infections or equipment contamination, as well as cross infections and colonization, in healthcare facilities? This includes randomized controlled trials or controlled clinical trials, and placebo or drug therapy, comparing copper-based interventions to randomized controlled trials or controlled clinical trials, and also to case reports or editorials.", "What is the effectiveness of copper-based materials and equipment in the prevention of infections, including those related to hospital-acquired infections and multiresistant bacteria, in healthcare facilities? This is the primary objective of a randomized controlled trial or controlled clinical trial, and the results of such studies have been widely reported in the literature."]}
{"id": "13", "boolean": "(\"Resource Allocation\"[Mesh] OR Resource[tiab] OR Resources[tiab] OR Allocation[tiab] OR Demand[tiab] OR \"Prognostic certainty\"[tiab] OR \"External validation\"[tiab] OR Prognosticative[tiab] OR Prognosticating[tiab] OR \"Validation cohort\"[tiab]) AND (\"Decision rule\"[tiab] OR \"Decision Support\"[tiab] OR Prediction[tiab] OR Predictions[tiab] OR Predictor[tiab] OR Predicting[tiab] OR Predictive[tiab] OR \"Scoring systems\"[tiab] OR \"Scoring system\"[tiab] OR \"Decision making\"[tiab] OR \"Preparedness strategies\"[tiab] OR \"Preparedness strategy\"[tiab] OR \"Prioritization Criteria\"[tiab] OR \"Prioritizing access\"[tiab] OR \"Consensus Statement\"[tiab] OR \"Categorization decisions\"[tiab] OR \"Allocation decisions\"[tiab] OR \"Clinical guidelines\"[tiab]) AND (\"Triage\"[Mesh] OR \"Patient Selection\"[Mesh] OR Triage[tiab] OR Triaging[tiab] OR Admission[tiab] OR Discharge[tiab] OR \"Incident management\"[tiab] OR \"Treatment priority\"[tiab] OR \"Patient volumes\"[tiab] OR ((Managing[tiab]) AND (Cohort[tiab])) OR (Calculators[tiab] AND Patients[tiab])) AND (\"Emergency Medical Services\"[Mesh] OR \"Critical Care\"[Mesh] OR \"Intensive Care Units\"[Mesh] OR \"Intensive care\"[tiab] OR \"Critical care\"[tiab] OR ICU[tiab] OR PICU[tiab] OR \"Critically ill\"[tiab] OR \"Life saving\"[tiab] OR Life-saving[tiab] OR Life-sustaining[tiab] OR \"Life sustaining\"[tiab] OR \"Life support\"[tiab] OR \"Short-term death\"[tiab] OR \"Short term death\"[tiab] OR \"Death prediction\"[tiab] OR Hospital[tiab] OR Hospitals[tiab] OR \"Emergency department\"[tiab] OR \"Emergency departments\"[tiab]) AND (\"Pandemics\"[Mesh] OR Disasters[Mesh] OR \"Hospital Mortality\"[Mesh] OR \"COVID-19\" OR Pandemic[tiab] OR Pandemics[tiab] OR Disaster[tiab] OR Disasters[tiab] OR \"SARS CoV 2\"[tiab] OR \"COVID 19\"[tiab] OR \"COVID-19\"[tiab] OR \"Mass casualty\"[tiab] OR \"Severe sepsis\"[tiab] OR \"Septic shock\"[tiab] OR \"Short-term mortality\"[tiab])", "generated_query": ["What is the effectiveness of resource allocation and decision rules, as well as patient selection and triage, in identifying and managing critically ill patients in intensive care units? This includes emergency medical services, critical care, and critically ill patients with short-term death, pandemics, disasters, hospital mortality, and clinical guidelines.", "What is the effectiveness of resource allocation and decision rules for emergency medical services, critical care, intensive care units, and hospitals in identifying patients at risk for pandemics, disasters, and hospital mortality, including COVID-19, SARS CoV 2, and other infectious diseases? Additionally, what are the benefits and drawbacks of using external validation, prognostic certainty, and predictive systems to determine prioritization criteria and patient volumes, and how do they compare to other criteria such as hospitalization, critical illness, and death prediction? Finally, what is the impact of resources and decision rules on hospital mortality, including those related to pandemics, disasters, and SARS CoV 2, and how do they compare to other measures such as patient volume and predictive systems?", "What are the decision rules, prediction algorithms, and triage criteria used to allocate resources in emergency medical services, critical care, intensive care units, and hospital mortality in the context of pandemics, disasters, and mass casualties?", "What is the effectiveness of resource allocation and triage systems for identifying and managing critically ill patients in emergency medical services, intensive care units, and hospitals? Additionally, what is the impact of external validation and prognostic certainty on these decision-making processes, and how do scoring systems and preparedness strategies improve the accuracy and reliability of resource allocation and triage decisions? Finally, what is the effectiveness of using critical illness and mortality data to manage and prevent pandemics, disasters, and hospital mortality, as well as viruses such as SARS CoV 2 and COVID 19, and the associated symptoms such as short-term mortality, severe sepsis, and septic shock?", "What is the effectiveness of resource allocation and decision support systems in managing emergency medical services, intensive care units, and critical illness? Additionally, what is the impact of these systems in identifying and treating critically ill patients, as well as those with pandemics or disasters, and how do they compare to hospital mortality or death prediction? Finally, what are the clinical guidelines and prioritization criteria for identifying and triaging patients, as well as the calculation of patient volumes and prognostic certainty, and how do they compare to patient outcomes?", "What is the effectiveness of Resource Allocation Decision Rules, Scoring Systems, and Triage Criteria for Emergency Medical Services, Critical Care, Intensive Care Units, and Hospitals in identifying patients with prognostic certainty, external validation, and prediction of short-term death or hospitalization?", "What is the effectiveness of resource allocation and decision rules for identifying and managing critically ill patients in emergency medical services, critical care, intensive care units, and critically ill patients? This includes the triage and patient selection processes, as well as the admission and discharge of critically ill patients. Additionally, what is the predictive accuracy of resource allocation and decision rules for prognostic certainty and external validation, and how do they compare to other resources, including clinical guidelines, triage, and prioritization criteria, for identifying and managing critically ill patients? Finally, what is the impact of resource allocation and decision rules on hospital mortality and pandemics, as well as the viruses SARS CoV 2 and COVID-19, and how do they compare to other resources, including clinical guidelines, triage, and prioritization criteria, for identifying and managing critically ill patients?", "What are the effectiveness of resource allocation and decision-making strategies for managing emergency medical services, intensive care units, and critical illness, as well as pandemics, disasters, and hospital mortality, and how do these strategies compare to triage, patient selection, and admission criteria?", "What is the effectiveness of resource allocation and decision support tools for identifying and triaging critically ill patients in emergency medical services, intensive care units, and critical care units? Additionally, what is the impact of predictive models and external validation on resource allocation and decision making? Finally, what are the implications of these tools for hospital mortality, pandemics, disasters, and short-term death?", "What is the effectiveness of resource allocation and decision rules for predicting clinical outcomes and prognostic certainty in patients with emergency medical services, critical care, intensive care units, and critical illness? This includes studies on triage, patient selection, and incident management, as well as those related to pandemics, disasters, hospital mortality, and cohorts. Additionally, what is the impact of resource allocation and decision rules on patient volumes, and how do they compare to scoring systems, clinical guidelines, and triage criteria?"]}
{"id": "66", "boolean": "(Aged[Mesh] OR Elderly[tiab] OR Older[tiab] OR decision-makers[tiab] OR Surrogates[tiab] OR Patients[tiab] OR Carers[tiab]) AND (\"Terminal Care\"[Mesh] OR \"Palliative Care\"[Mesh] OR \"Frail Elderly\"[Mesh] OR \"End of life\"[tiab] OR \"Last year of life\"[tiab] OR \"Limited life\"[tiab] OR Frail[tiab] OR Death[tiab] OR Dying[tiab] OR Palliative[tiab] OR \"Intensive care\"[tiab]) AND (\"Patient Preference\"[Mesh] OR Perception[tiab] OR perspective[tiab] OR perceived[tiab] OR experience[tiab] OR Experiences[tiab] OR opinion[tiab] OR views[tiab] OR satisfaction[tiab] OR discordance[tiab] OR discrepancy[tiab] OR dissonance[tiab]) AND (Consultation[tiab] OR Communication[tiab] OR \"focus groups\"[tiab] OR \"Focus group\"[tiab]) AND (\"Surveys and Questionnaires\"[Mesh] OR \"Interviews as Topic\"[Mesh] OR Qualitative[tiab] OR Surveys[tiab] OR questionnaires[tiab] OR Interview[tiab] OR Interviews[tiab] OR Survey[tiab] OR \"Thematic analysis\"[tiab])", "generated_query": ["What is the effectiveness of patient preference consultation and communication in providing terminal care for elderly patients? This includes studies on frail elderly, end of life, last year of life, limited life, and death. Additionally, what are the benefits of surveys and questionnaires, as well as interviews and qualitative analysis, in understanding patients' perspectives and experiences?", "What is the impact of patient preference and patient experience on the delivery of terminal and palliative care to aged and frail patients? This includes studies on decision-makers, surrogates, patients, carers, and consultation, as well as surveys and questionnaires, interviews, and thematic analysis.", "What are the most effective communication and consultation techniques for end-of-life decision-makers and surrogates, including patients, carers, and decision-makers, in terminal and palliative care, frail elderly, end of life, and limited life? This includes surveys and questionnaires, interviews, and thematic analysis of the perceptions and experiences of patients and their families.", "What are the preferences and experiences of patients and decision-makers in terminal care and palliative care, including those who are elderly or frail, and how do these preferences affect the way in which patients are cared for? This includes communication and consultation, as well as surveys and questionnaires, interviews, and thematic analysis.", "What is the effectiveness of terminal care and palliative care in improving the quality of life for aged decision-makers, surrogates, and patients, as well as their families and carers, by consulting them in advance and providing them with surveys and questionnaires, interviews, and thematic analysis?", "What is the effectiveness of using patient preference surveys and qualitative research to improve end-of-life care for aged individuals, including those with frail health or limited life, in intensive care settings?", "What is the effectiveness of surveys and questionnaires, as well as interviews and focus groups, in improving patient preference and experience, as well as decision-maker and surrogate perspectives, for those individuals who are aged, elderly, frail, or dying, and for whom intensive care may be an appropriate option?", "What is the impact of patient preference and decision-making on the delivery of terminal care, palliative care, frail elderly, end of life, last year of life, limited life, frail, death, dying, palliative, intensive care, and surveys and questionnaires? Additionally, what is the effectiveness of consultation, communication, focus groups, and thematic analysis in gathering patient perspectives and experiences?", "What is the effectiveness of patient preferences and perspectives on terminal care, palliative care, frail elderly, end of life, last year of life, limited life, frail, death, and surveys and questionnaires in decision-making and care for aged patients?", "What is the effectiveness of patient preference and surrogate decision-making in terminal care, palliative care, frail elderly, end of life, last year of life, limited life, frail, death, and surveys and questionnaires in improving patient experience and satisfaction?"]}
{"id": "14", "boolean": "(\"COVID-19\"[Supplementary Concept] OR \"COVID-19\"[tiab] OR COVID19[tiab] OR \"COVID 19\"[tiab] OR \"SARS-CoV-2\"[tiab] OR \"2019-nCoV\"[tiab] OR \"Novel coronavirus\"[tiab] OR \"Coronavirus 2019\"[tiab] OR \"Coronavirus 19\"[tiab] OR \"COVID 2019\"[tiab] OR \"2019 ncov\"[tiab] OR \"Wuhan coronavirus\"[tiab]) AND (((Pandemic[ti] OR Pandemics[ti] OR Outbreak[ti] OR Outbreaks[ti] OR Hospital[ti] OR Hospitals[ti] OR Emergency[ti] OR Surgery[ti] OR Surgical[ti] OR Department[ti] OR Departments[ti] OR Unit[ti] OR Units[ti] OR Clinic[ti] OR Clinics[ti] OR \"Primary care\"[ti]) AND (Admission[ti] OR Admissions[ti] OR Visit[ti] OR Visits[ti] OR Attendance[ti] OR Attending[ti] OR Activity[ti] OR Utilization[ti] OR Utilisation[ti] OR Impact[ti] OR Impacts[ti] OR Reduction[ti] OR Reductions[ti] OR Decrease[ti] OR Decreases[ti] OR Decreased[ti] OR Decline[ti] OR Decline[ti] OR Change[ti] OR Changes[ti] OR Increase[ti] OR Increases[ti] OR Increased[ti])) OR ((Pandemic[tiab] OR Pandemics[tiab] OR Outbreak[tiab] OR Outbreaks[tiab]) AND (((Hospital[tiab] OR Hospitals[tiab] OR Emergency[tiab] OR Surgery[tiab] OR Surgical[tiab] OR Department[tiab] OR Departments[tiab] OR Unit[tiab] OR Units[tiab] OR Clinic[tiab] OR Clinics[tiab] OR \"Primary care\"[tiab] OR Telemedicine[tiab] OR Telehealth[tiab]) AND (Admission[tiab] OR Admissions[tiab] OR Visit[tiab] OR Visits[tiab] OR Attendance[tiab] OR Attending[tiab] OR Activity[tiab] OR Utilization[tiab] OR Utilisation[tiab])) OR (Prescriptions[tiab] OR Prescribed[tiab] OR Vaccinations[tiab] OR Imaging[tiab] OR Scans[tiab] OR Endoscopy[tiab] OR Endoscopic[tiab] OR Endoscopies[tiab])) AND (Impact[tiab] OR Impacts[tiab] OR Reduction[tiab] OR Reductions[tiab] OR Decrease[tiab] OR Decreases[tiab] OR Decreased[tiab] OR Decline[tiab] OR Declines[tiab] OR Changes[tiab] OR Increase[tiab] OR Increases[tiab] OR Increased[tiab])))", "generated_query": ["What is the effectiveness of telemedicine and prescriptions/vaccinations/imaging/scans/endoscopy/endoscopy in reducing the impact of COVID-19, including hospitalization and prescriptions, as compared to primary care or hospital-based care, on the spread of the disease?", "What is the impact of COVID-19 on primary care utilization and prescriptions, as well as hospitalization and surgery, and how do changes in healthcare delivery affect the spread of the virus?", "What is the impact of COVID-19 pandemics on healthcare utilization and prescriptions, as well as vaccinations and imaging, in primary care clinics? This includes hospital admissions, visits, and activity, as well as prescriptions, vaccinations, and imaging, in the context of impairment of primary care services due to the pandemic?", "What is the effectiveness of using telemedicine and prescriptions/vaccines/hospital admissions/visits/attendance/activity/and utilization in reducing morbidity and mortality in the coronavirus pandemic, and how do they impact the primary care system?", "What is the effectiveness of telemedicine and prescriptions/vaccinations/imaging/scans/endoscopy/endoscopic/endoscopies in reducing morbidity and mortality in both children and adults during the COVID-19 pandemic, as compared to in-person care, in hospital emergency departments and clinics, and involving primary care physicians?", "What is the impact of COVID-19 on primary care utilization and prescriptions, as well as hospitalization and emergency department visits, and how do changes in these metrics affect vaccinations, imaging, and scans?", "What is the impact of social media and telemedicine on the admission and utilization of health care services during the COVID-19 pandemic, including hospitals, emergency and surgical departments, units, and clinics, as well as primary care and telehealth providers, and the prescription and vaccination of patients? Specifically, how do social media and telemedicine affect the reduction of pandemic-related healthcare costs, including those related to hospitalization, surgery, and prescriptions, as well as vaccines and imaging, and how do they improve the overall healthcare system?", "What is the impact of telemedicine and prescriptions/vaccinations/imaging/scans/endoscopy/endoscopic/endoscopies on the admission/attendance/activity/utilization/impact/reduction/decrease/decreases/clinic/counseling/telehealth/vaccines/hospitals/pandemics/outbreaks/department/units/clinical/primary/telemedicine/telehealth/prescriptions/vaccinations/imaging/scans/endoscopy/endoscopic/endoscopies/ and changes in COVID-19, SARS-CoV-2, 2019-nCoV, Novel coronavirus, Coronavirus 19, 2019, 2019 ncov, Wuhancovirus, and Pandemic/Pandemics?", "What is the impact of coronavirus pandemic, as well as hospital and primary care utilization, on the prescription and vaccination of COVID-19 and SARS-CoV-2, as well as other related viruses such as 2019-nCoV, Novel coronavirus, and Coronavirus 19, and how do changes in vaccination and prescription patterns affect the development or progression of the virus?", "What is the impact of COVID-19 on healthcare systems, including hospitals, emergency surgery, and telemedicine, and how do changes in prescriptions and imaging affect the development or progression of the pandemic?"]}
{"id": "1", "boolean": "(\"Telemedicine\"[Mesh] OR \"Videoconferencing\"[Mesh] OR Telehealth[tiab] OR Telemedicine[tiab] OR Videoconferencing[tiab] OR ((Telephone[tiab]) AND (Consultation[tiab] OR face-to-face[tiab] OR in-person[tiab])) OR telephone-delivered[tiab]) AND (\"Primary Health Care\"[Mesh] OR \"General Practice\"[Mesh] OR rehabilitation[sh] OR \"Outpatients\"[Mesh] OR \"Speech Therapy\"[Mesh] OR Outpatient[tiab] OR \"Primary health\"[tiab] OR \"Primary care\"[tiab] OR \"General practice\"[tiab] OR \"General practices\"[tiab] OR \"General practitioners\"[tiab] OR \"General practitioner\"[tiab] OR \"Family practice\"[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR Therapist[tiab] OR Nurse[tiab] OR Nurses[tiab] OR Physiotherapist[tiab] OR Rehabilitation[tiab] OR Diabetes[tiab] OR Diabetic[tiab] OR Asthma[tiab] OR Depression[tiab] OR \"\u00cfrritable bowel\"[tiab] OR IBS[tiab] OR PTSD[tiab] OR \"Chronic fatigue\"[tiab]) AND ((Face to face[tiab]) OR \"Usual care\"[tiab] OR Visits[tiab] OR Visit[tiab] OR In-person[tiab] OR \"In person\"[tiab] OR ((Clinic[tiab] OR Centre[tiab] OR Home[tiab]) AND (Based[tiab] OR Contact[tiab])) OR Conventional[tiab] OR \"Practice-based\"[tiab] OR \"Practice based\"[tiab] OR Traditional[tiab] OR \"Standard care\"[tiab] OR Homecare[tiab] OR ((Routine[tiab] OR Home[tiab]) AND (Care[tiab]))) AND (\"Delivery of Health Care\"[Mesh] OR Delivery[tiab] OR Delivered[tiab] OR Via[tiab] OR Received[tiab]) AND (\"Treatment Outcome\"[Mesh] OR \"Patient Satisfaction\"[Mesh] OR Therapy[sh] OR Diagnosis[sh] OR \"Clinical outcomes\"[tiab] OR Treatment[tiab] OR Diagnostic[tiab] OR Efficacy[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT  (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (\"Case Reports\"[pt] OR Editorial[pt] OR Letter[pt] OR Meta-Analysis[pt] OR \"Observational Study\"[pt] OR \"Systematic Review\"[pt] OR \"Case Report\"[ti] OR \"Case series\"[ti] OR Meta-Analysis[ti] OR \"Meta Analysis\"[ti] OR \"Systematic Review\"[ti] OR \"Systematic Literature Review\"[ti] OR \"Qualitative study\"[ti] OR Protocol[ti])", "generated_query": ["What is the effectiveness of telemedicine, videoconferencing, and speech therapy in the diagnosis and treatment of primary healthcare conditions, including general practice, rehabilitation, outpatients, and speech therapy, as well as randomized controlled trials and controlled clinical trials?", "What is the effectiveness of telemedicine and videoconferencing in the delivery of primary health care, including rehabilitation, outpatients, and speech therapy, as compared to in-person care, for the diagnosis and management of diabetic patients, as evaluated in randomized controlled trials? Additionally, how do telemedicine and videoconferencing impact the treatment outcome and patient satisfaction of diabetic patients?", "What is the effectiveness of telemedicine, videoconferencing, and speech therapy in the delivery of primary health care, rehabilitation, and outpatient services, including those related to diabetes, asthma, depression, and other conditions, as evaluated through randomized controlled trials and clinical outcomes?", "What are the effectiveness of telemedicine and videoconferencing in the delivery of health care and treatment outcome in primary health care and general practice, including rehabilitation, outpatient, and speech therapy, as compared to face-to-face visits or clinical outcomes, for the diagnosis and management of a range of conditions, including diabetes, asthma, chronic fatigue, and PTSD?", "What are the most effective telemedicine and videoconferencing platforms for delivering healthcare and treatment outcomes, including randomized controlled trials and placebo-controlled studies, as compared to face-to-face visits or inpatient care, in primary healthcare, general practice, rehabilitation, outpatients, speech therapy, and other related conditions?", "What is the effectiveness of telemedicine and videoconferencing in the delivery and treatment of primary health care, including rehabilitation, outpatient, speech therapy, and diagnostic accuracy, as compared to face-to-face visits and randomized controlled trials, for the diagnosis and management of common conditions such as diabetes, asthma, and depression? Additionally, how do these treatments compare to placebo or drug therapy, as well as systematic reviews and qualitative studies, for the prevention and management of these conditions?", "What is the effectiveness of telemedicine, videoconferencing, and speech therapy in the delivery of primary healthcare, including rehabilitation, outpatient visits, and clinical outcomes, as compared to face-to-face care, for the treatment of chronic fatigue, asthma, diabetes, and other conditions? Additionally, what is the effectiveness of telemedicine and videoconferencing in diagnosing and managing mental health conditions such as depression and PTSD, and delivering randomized controlled trials or controlled clinical trials for treatment outcome and patient satisfaction?", "What is the effectiveness of telemedicine and videoconferencing in the delivery of primary health care, including rehabilitation and outpatient services, as compared to face-to-face or usual care, in achieving treatment outcome and patient satisfaction, as evaluated by randomized controlled trials or controlled clinical trials, and in diagnostic accuracy and clinical outcomes?", "What is the effectiveness of telemedicine and videoconferencing in the diagnosis and treatment of primary health care patients, including those with rehabilitation needs, outpatients, and speech therapy? Additionally, what are the randomized controlled trials or controlled clinical trials that have investigated their efficacy? Finally, what is the delivery of healthcare and treatment outcome as evaluated by patients or healthcare providers?", "What is the effectiveness of telemedicine, videoconferencing, and other forms of telehealth in the diagnosis and treatment of primary health care conditions, including rehabilitation, outpatients, and in-person visits? Additionally, what are the clinical outcomes and treatment efficacy of randomized controlled trials or controlled clinical trials, as well as placebo or drug therapy, in reducing morbidity and mortality in both humans and animals? Finally, what are the qualitative and protocol-based effects of telemedicine, videoconferencing, and other forms of telehealth in the diagnosis and treatment of primary health care conditions?"]}
{"id": "52", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR \"Fluoroquinolones\"[Mesh] OR \"Sulfonamides\"[Mesh] OR \"Tetracyclines\"[Mesh] OR \"Aminoglycosides\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab]) AND (\"Placebos\"[Mesh] OR Placebos[tiab] OR Placebo[tiab] OR Placeboes[tiab] OR \"Sham treatment\"[tiab] OR \"No treatment\"[tiab]) AND (\"Urinary Tract Infections\"[Mesh] OR \"Urinary Tract Infections\"[tiab] OR \"Urinary Tract Infection\"[tiab] OR UTIs[tiab] OR UTI[tiab] OR Cystitis[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, and other agents, in the treatment of urinary tract infections? Additionally, are there any randomized controlled trials or controlled clinical trials that have investigated their efficacy? Finally, are there any placebo or sham treatment studies that have investigated their effectiveness?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and antibiotics, in treating urinary tract infections?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluroquinolones, sulfonamides, tetracyclines, aminoglycosides, and antibiotics, in the treatment of urinary tract infections? Are there any randomized controlled trials or controlled clinical trials that have investigated their efficacy?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and antibiotics, in the treatment of urinary tract infections? This question can be answered through randomized controlled trials or controlled clinical trials, as well as placebo or sham treatment, and the drugs or agents should not be administered to animals, humans, or groups of people.", "What is the effectiveness of anti-bacterial agents, including Macrolides, beta-lactams, Fluoroquinolones, Sulfonamides, Tetracyclines, Aminoglycosides, Antibacterial, Antibacterials, Antibiotics, Antibiotic, Macrolides, Macrolide, beta-lactams, Fluoroquinolones, Sulfonamides, Tetracyclines, Aminoglycosides, Antimicrobial, Antimicrobials, Penicillin, Methicillin, ampicillin, azithromycin, Clarithromycin, Ketolides, Roxithromycin, Filipin, Ivermectin, Josamycin, Leucomycins, Kitasamycin, Spiramycin, Carbapenems, Thienamycins, and Cephalosporins, in treating urinary tract infections? Additionally, what is the efficacy of placebo or randomized controlled trials or controlled clinical trials or randomized or randomises or placebo or drug", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, and aminoglycosides, in the treatment of urinary tract infections? This question has been investigated in randomized controlled trials and controlled clinical trials, in which placebo or drug therapy was compared to placebo or randomized groups in animals or humans.", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, flouroquinolones, sulfonamides, and tetracyclines, in treating urinary tract infections or cystitis? This question is addressed in randomized controlled trials or controlled clinical trials, as well as in placebo-controlled studies, and the drugs are administered to both animals and humans.", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluroquinolones, sulfonamides, tetracyclines, aminoglycosides, and antibiotics, in treating urinary tract infections? Are there any randomized controlled trials or controlled clinical trials that have investigated their efficacy?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluroquinolones, sulfonamides, Tetracyclines, Aminoglycosides, Antibiotics, and Placebos, in treating urinary tract infections or cystitis? This includes randomized controlled trials or controlled clinical trials, as well as placebo or sham treatments, and may also include animals or humans.", "What is the effectiveness of anti-bacterial agents and placebo or other treatments in the diagnosis and management of urinary tract infections?"]}
{"id": "53", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR \"Fluoroquinolones\"[Mesh] OR \"Sulfonamides\"[Mesh] OR \"Tetracyclines\"[Mesh] OR \"Aminoglycosides\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab]) AND (\"Placebos\"[Mesh] OR Placebos[tiab] OR Placebo[tiab] OR Placeboes[tiab] OR \"Sham treatment\"[tiab] OR \"No treatment\"[tiab] OR \"No active treatment\"[tiab]) AND (\"Respiratory Tract Infections\"[Mesh] OR Nasopharyngitis[Mesh] OR Rhinitis[Mesh] OR Sinusitis[Mesh] OR Pharyngitis[Mesh] OR Laryngitis[Mesh] OR bronchitis[Mesh] OR bronchiolitis[Mesh] OR \"bronchiolitis, viral\"[Mesh] OR Pleurisy[Mesh] OR Cough[Mesh] OR Sneezing[Mesh] OR Pneumonia[Mesh] OR \"Respiratory Sounds\"[Mesh] OR \"Otitis Media\"[Mesh] OR Earache[Mesh] OR \"Influenza, Human\"[Mesh] OR \"Common Cold\"[Mesh] OR \"Respiratory infection\"[tiab] OR \"Respiratory infections\"[tiab] OR \"Respiratory Tract Infections\"[tiab] OR \"Respiratory Tract Infection\"[tiab] OR \"Respiratory inflammation\"[tiab] OR \"Respiratory tract inflammation\"[tiab] OR urti[tiab] OR lrti[tiab] OR ari[tiab] OR nasopharyngitis[tiab] OR rhinopharyngitis[tiab] OR sinusitis[tiab] OR nasosinusitis[tiab] OR rhinosinusitis[tiab] OR rhinitis[tiab] OR rhinorrhoea[tiab] OR rhinorrhea[tiab] OR pharyngitis[tiab] OR \"sore throat\"[tiab] OR Tonsillitis[tiab] OR laryngitis[tiab] OR croup[tiab] OR pseudocroup[tiab] OR tracheobronchitis[tiab] OR laryngotracheobronchitis[tiab] OR bronchitis[tiab] OR bronchiolitis[tiab] OR pneumonia[tiab] OR pleuropneumonia[tiab] OR bronchopneumonia[tiab] OR pleurisy[tiab] OR cough[tiab] OR Wheeze[tiab] OR Wheezing[tiab] OR \"otitis media\"[tiab] OR aom[tiab] OR ome[tiab] OR earache[tiab] OR influenza[tiab] OR flu[tiab] OR \"common cold\"[tiab] OR \"common colds\"[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What are the most effective anti-bacterial agents or drugs for treating respiratory tract infections, including nasopharyngitis, rhinitis, sinusitis, pharyngitis, laryngitis, bronchitis, bronchiolitis, pneumonia, pleuropneumonia, bronchopneumonia, and pleurisy, as well as their associated symptoms such as sore throat, tonsillitis, and pneumonia?", "What is the effectiveness of anti-bacterial agents, including beta-lactams, fluoroquinolones, sulfonamides, and tetracyclines, in the treatment of respiratory tract infections, including bronchitis, emphysema, and pneumonia, as well as other conditions such as influenza, common cold, and trials or placebo interventions?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, antimicrobials, and placebo or sham treatment, in the diagnosis and management of respiratory tract infections, including nasopharyngitis, rhinitis, sinusitis, pharyngitis, laryngitis, bronchitis, bronchiolitis, pneumonia, pleuropneumonia, bronchopneumonia, and pleurisy, as well as respiratory sounds, otitis media, and aom?", "What is the effectiveness of anti-bacterial agents, including beta-lactams, flouroquinolones, sulfonamides, tetracyclines, and aminoglycosides, in treating respiratory tract infections? This question is investigated through randomized controlled trials and controlled clinical trials, as well as placebo or drug therapy, in both animals and humans.", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluroquinolones, sulfonamides, tetracyclines, and aminoglycosides, in treating respiratory tract infections? This includes randomized controlled trials or controlled clinical trials, as well as placebo or drug therapy, in animals and humans.", "What are the most effective anti-bacterial agents for treating respiratory tract infections, including placebo or drug therapy, as compared to randomized controlled trials or controlled clinical trials?", "What are the most effective anti-bacterial agents for treating respiratory tract infections, including those related to the sinuses, nose, and throat? This includes placebo or other treatments, as evaluated in randomized controlled trials or controlled clinical trials.", "What is the effectiveness of anti-bacterial agents and drugs in treating respiratory tract infections, including bronchitis, emphysema, and pneumonia, as well as influenza and common cold symptoms, as compared to placebo or randomized controlled trials or controlled clinical trials, and how do they affect animals and humans?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, and tetracyclines, in treating respiratory tract infections, including nasopharyngitis, rhinitis, sinusitis, and pharyngitis, as well as their associated symptoms such as sore throat, tonsillitis, laryngitis, bronchitis, bronchiolitis, pneumonia, and pleurisy? Additionally, what is the effectiveness of randomized controlled trials or controlled clinical trials in treating these conditions? Finally, do the agents have any adverse effects in animals, including humans, that are not associated with these respiratory tract infections?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, and other agents, in the treatment of respiratory tract infections, including nasopharyngitis, rhinitis, sinusitis, pharyngitis, laryngitis, bronchitis, bronchiolitis, pneumonia, and pleuropneumonia, as well as randomized controlled trials or controlled clinical trials?"]}
{"id": "8", "boolean": "(Physicians[Mesh] OR Doctor[tiab] OR Doctors[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR \"General practitioner\"[tiab] OR \"General practitioners\"[tiab] OR Cardiologist[tiab] OR Cardiologists[tiab] OR Dermatologist[tiab] OR Dermatologists[tiab] OR Endocrinologist[tiab] OR Endocrinologists[tiab] OR Gastroenterologist[tiab] OR Gastroenterologists[tiab] OR Geriatrician[tiab] OR Geriatricians[tiab] OR Neurologist[tiab] OR Neurologists[tiab] OR Oncologist[tiab] OR Oncologists[tiab] OR Obstetrician[tiab] OR Obstetricians[tiab] OR Pediatrician[tiab] OR Pediatricians[tiab] OR Paediatrician[tiab] OR Paediatricians[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR \"Family Physician\"[tiab] OR \"Family Physicians\"[tiab] OR Surgeon[tiab] OR Surgeons[tiab] OR Urologist[tiab] OR Urologists[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR Resident[tiab] OR Residents[tiab] OR Registrar[tiab] OR Registrars[tiab] OR Consultant[tiab] OR Consultants[tiab] OR Specialist[tiab] OR Specialists[tiab]) AND (\"Practice Patterns, Physicians\"[Mesh] OR \"Clinical Competence\"[Mesh] OR Individual[tiab] OR Individuals[tiab]) AND (Variability[tiab] OR Variation[tiab] OR Vary[tiab]) AND (\"Outcome and Process Assessment, Health Care\"[Mesh] OR \"Quality of Health Care\"[Mesh] OR \"Patient Care\"[Mesh] OR \"Patient care\"[tiab] OR \"Care quality\"[tiab] OR ((Treatment[tiab] OR Medical[tiab] OR Surgical[tiab]) AND (Outcome[tiab] OR Outcomes[tiab]))) AND (\"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"Case control\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR \"Cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]) AND (Doctor[ti] OR Doctors[ti] OR Physician[ti] OR Physicians[ti] OR Clinician[ti] OR Clinicians[ti] OR \"General practitioner\"[ti] OR \"General practitioners\"[ti] OR Cardiologist[ti] OR Cardiologists[ti] OR Dermatologist[ti] OR Dermatologists[ti] OR Endocrinologist[ti] OR Endocrinologists[ti] OR Gastroenterologist[ti] OR Gastroenterologists[ti] OR Geriatrician[ti] OR Geriatricians[ti] OR Neurologist[ti] OR Neurologists[ti] OR Oncologist[ti] OR Oncologists[ti] OR Obstetrician[ti] OR Obstetricians[ti] OR Pediatrician[ti] OR Pediatricians[ti] OR Paediatrician[ti] OR Paediatricians[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR \"Family Physician\"[ti] OR \"Family Physicians\"[ti] OR Surgeon[ti] OR Surgeons[ti] OR Urologist[ti] OR Urologists[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR Resident[ti] OR Residents[ti] OR Registrar[ti] OR Registrars[ti] OR Consultant[ti] OR Consultants[ti] OR Specialist[ti] OR Specialists[ti] OR Individual[ti] OR Individuals[ti] OR Variability[ti] OR Variation[ti] OR Vary[ti] OR \"Patient care\"[ti] OR \"Care quality\"[ti] OR ((Treatment[ti] OR Medical[ti] OR Surgical[ti]) AND (Outcome[ti] OR Outcomes[ti])))", "generated_query": ["What are the practice patterns and clinical competence of physicians, including doctors, cardiologists, gastroenterologists, neurologists, oncologists, obstetrician, pediatricians, and psychiatrists, in terms of their patient care and outcome assessment? Additionally, what are the associated epidemiologic studies, case-control studies, and cross-sectional studies? Finally, what are the statistical and numerical data, and what is the quality of healthcare, as evaluated by physicians and patients, for treatments and outcomes?", "What is the effectiveness of doctors' practice patterns and clinical competence in delivering quality health care to patients? This includes assessing outcome and process assessment, epidemiological studies, and case-control studies.", "What are the practice patterns and clinical competence of physicians, including cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetricians, pediatricians, and psychiatrists, as well as their residents and registrars, in terms of outcomes and processes of care for their patients?", "What is the practice pattern of physicians and clinicians in terms of outcome and process assessment, health care quality, and patient care? This includes studies on epidemiology, doctors, and psychiatrists, as well as cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetrician, pediatrician, and psychiatrists. Additionally, what is the effectiveness of patient care, care quality, and outcome assessment, as well as the variation and variation in care?", "What are the effectiveness of physicians' practice patterns and clinical competence, as measured by outcome and process assessments, health care quality, and patient care, in treating patients with cardiovascular disease or related conditions? This includes epidemiological studies, case-control studies, and cohort studies, as well as individual and group-level variations and patient-care outcomes.", "What is the impact of practice patterns, clinical competence, and outcome assessment in the delivery of healthcare, including cardiology, dermatology, endocrinology, gastroenterology, geriatrics, neurology, oncology, obstetrics, pediatrics, and psychiatry?", "What is the effectiveness of doctors' practice patterns and clinical competence in improving patient care and outcome? This includes epidemiologic studies and randomized controlled trials that have investigated the effectiveness of doctors' practice patterns and clinical competence in reducing variability and improving care quality.", "What are the effectiveness of physician practice patterns and clinical competence, as measured by outcome and process assessment, health care, and quality of care, in achieving positive patient outcomes? Additionally, what is the association between physician practice patterns and treatment outcome, as evaluated in epidemiological studies, and how do changes in practice patterns affect the likelihood of positive patient outcomes?", "What is the effectiveness of doctors and clinicians in treating patients, as compared to placebo or other interventions, for a variety of conditions? This includes studies that have investigated their outcome and process assessment, health care quality, and patient care, as well as those that have employed various epidemiological and statistical methods.", "What is the effectiveness of physician practice patterns and clinical competence in providing quality health care to patients? This includes epidemiologic studies, case-control studies, cohort studies, and investigations of statistics and numerical data. Additionally, what is the effectiveness of outcome and process assessment in identifying and addressing variations and changes in practice patterns?"]}
{"id": "112", "boolean": "(Physicians[Mesh] OR Doctor[tiab] OR Doctors[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR \"General practitioner\"[tiab] OR \"General practitioners\"[tiab] OR Cardiologist[tiab] OR Cardiologists[tiab] OR Dermatologist[tiab] OR Dermatologists[tiab] OR Endocrinologist[tiab] OR Endocrinologists[tiab] OR Gastroenterologist[tiab] OR Gastroenterologists[tiab] OR Geriatrician[tiab] OR Geriatricians[tiab] OR Neurologist[tiab] OR Neurologists[tiab] OR Oncologist[tiab] OR Oncologists[tiab] OR Obstetrician[tiab] OR Obstetricians[tiab] OR Pediatrician[tiab] OR Pediatricians[tiab] OR Paediatrician[tiab] OR Paediatricians[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR \"Family Physician\"[tiab] OR \"Family Physicians\"[tiab] OR Surgeon[tiab] OR Surgeons[tiab] OR Urologist[tiab] OR Urologists[tiab] OR Psychiatrist[tiab] OR Psychiatrists[tiab] OR Resident[tiab] OR Residents[tiab] OR Registrar[tiab] OR Registrars[tiab] OR Consultant[tiab] OR Consultants[tiab] OR Specialist[tiab] OR Specialists[tiab]) AND (\"Practice Patterns, Physicians\"[Mesh] OR \"Clinical Competence\"[Mesh] OR Individual[tiab] OR Individuals[tiab]) AND (Variability[tiab] OR Variation[tiab] OR Vary[tiab]) AND (\"Outcome and Process Assessment, Health Care\"[Mesh] OR \"Quality of Health Care\"[Mesh] OR \"Patient Care\"[Mesh] OR \"Patient care\"[tiab] OR \"Care quality\"[tiab] OR ((Treatment[tiab] OR Medical[tiab] OR Surgical[tiab]) AND (Outcome[tiab] OR Outcomes[tiab]))) AND (\"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"Case control\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR \"Cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]) AND (Doctor[ti] OR Doctors[ti] OR Physician[ti] OR Physicians[ti] OR Clinician[ti] OR Clinicians[ti] OR \"General practitioner\"[ti] OR \"General practitioners\"[ti] OR Cardiologist[ti] OR Cardiologists[ti] OR Dermatologist[ti] OR Dermatologists[ti] OR Endocrinologist[ti] OR Endocrinologists[ti] OR Gastroenterologist[ti] OR Gastroenterologists[ti] OR Geriatrician[ti] OR Geriatricians[ti] OR Neurologist[ti] OR Neurologists[ti] OR Oncologist[ti] OR Oncologists[ti] OR Obstetrician[ti] OR Obstetricians[ti] OR Pediatrician[ti] OR Pediatricians[ti] OR Paediatrician[ti] OR Paediatricians[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR \"Family Physician\"[ti] OR \"Family Physicians\"[ti] OR Surgeon[ti] OR Surgeons[ti] OR Urologist[ti] OR Urologists[ti] OR Psychiatrist[ti] OR Psychiatrists[ti] OR Resident[ti] OR Residents[ti] OR Registrar[ti] OR Registrars[ti] OR Consultant[ti] OR Consultants[ti] OR Specialist[ti] OR Specialists[ti] OR Individual[ti] OR Individuals[ti] OR Variability[ti] OR Variation[ti] OR Vary[ti] OR \"Patient care\"[ti] OR \"Care quality\"[ti] OR ((Treatment[ti] OR Medical[ti] OR Surgical[ti]) AND (Outcome[ti] OR Outcomes[ti])))", "generated_query": ["What are the physicians' practice patterns and clinical competence, as well as the variability and outcome of treatments, as evaluated by epidemiologic studies?", "What is the effectiveness of physicians' practice patterns and clinical competence in delivering quality care to patients? This includes epidemiological studies and data analysis, as well as individual and group variations, in order to assess outcomes and process assessment in health care.", "What are the practice patterns and clinical competence of physicians, including cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetrician, and pediatrician, as well as their associated outcomes and process assessments, and how do they compare to other healthcare providers? Additionally, what are the epidemiological studies and patient care quality of physicians, including general practitioners and surgeons, and how do they compare to other healthcare providers?", "What are the effectiveness of physicians' practice patterns and clinical competence, as evaluated by epidemiologic studies and patient care, in the diagnosis and treatment of a variety of conditions, including cardiology, dermatology, endocrinology, gastroenterology, geriatrics, neurology, oncology, obstetrics, pediatrics, and psychiatry?", "What are the practice patterns and clinical competence of physicians and doctors, as well as their associated treatments and outcomes, in providing quality care to patients? This includes studies of variability and variation in care, and the patient care and outcome that results from their treatments.", "What are the practice patterns and clinical competence of doctors and clinicians, including general practitioners, cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetrician, and pediatrician, as well as those with specialist or individual status? Additionally, what are the outcomes and processes of care for patients, including those with retrospective or prospective studies, and how do treatments and medicines affect the care provided?", "What are the clinical competence and outcome of doctors and clinicians in treating patients? Additionally, what is the effectiveness of epidemiologic studies and case-control studies in detecting and monitoring patient care and outcome?", "What are the practice patterns and clinical competence of physicians, including doctors, phsyicists, and specialists, as evaluated by outcome and process assessment, health care quality, and patient care, as compared to epidemiic studies and cross-sectional studies, and how do they affect the care of patients with varied outcomes?", "What are the doctor and patient care quality outcomes for physical therapists and other health care professionals, including cardiologists, dermatologists, endocrinologists, gastroenterologists, geriatricians, neurologists, oncologists, obstetrician, pediatrician, and psychiatrist, as well as individual and institutional practice patterns and epidemiological studies? Additionally, what is the effectiveness of outcome and process assessments, including clinical competence and patient care, for identifying and addressing treatment and medical errors?", "What are the clinical competence and outcome assessment of doctors, clinicians, and family physicians? This includes investigating and analyzing data from epidemiologic studies and case-control studies, as well as the variance and variation in patient care and treatment outcome."]}
{"id": "51", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab]) AND (\"Placebos\"[Mesh] OR Placebos[tiab] OR Placebo[tiab] OR Placeboes[tiab] OR \"Sham treatment\"[tiab]) AND (Erysipelas[Mesh] OR erysipelas[tiab] OR \"Skin Diseases, Infectious\"[Mesh] OR Cellulitis[Mesh] OR cellulitis[tiab] OR impetigo[tiab] OR Impetigo[Mesh] OR \"Soft Tissue Infections\"[Mesh] OR \"Ignis sacer\"[tiab] OR \"holy fire\"[tiab] OR \"st anthony's fire\"[tiab] OR \"Soft Tissue Infections\"[tiab] OR \"Soft Tissue Infection\"[tiab] OR \"Skin infections\"[tiab] OR \"Skin infection\"[tiab] OR ((*Staphylococcus[Mesh] OR staphylococc*[tiab] OR Streptococcus[Mesh] OR streptococc*[tiab]) AND Skin[Mesh]))", "generated_query": ["What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in the treatment of skin diseases such as erysipelas, cellulitis, impetigo, and soft tissue infections? Placebo or sham treatments were used in some studies, and staphylocccus or streptococcus were found in some studies.", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in the treatment of erysipelas, cellulitis, impetigo, or staphylocccal skin conditions? Placebo or sham treatments are also effective, as are other agents such as ignis sacer, holy fire, st anthony's fire, soft tissue infections, or skin infections.", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in the treatment of skin diseases such as erysipelas, cellulitis, impetigo, and soft tissue infections? Placebo or sham treatment is also included in the study.", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in the treatment of skin diseases such as erysipelas, cellulitis, impetigo, and soft tissue infections?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in the treatment of erysipelas, skin infections, and soft tissue infections? Additionally, what is the effectiveness of placebo or sham treatments in comparison to anti-bacterial agents in reducing morbidity and mortality in these conditions? Finally, what is the effectiveness of anti-bacterial agents in the diagnosis and prevention of staphylocccus and streptococcus infections?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in the treatment of skin diseases, including erysipelas, cellulitis, impetigo, and staphylococcal infections? Additionally, what is the effectiveness of placebo or sham treatments in these conditions?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in treating skin diseases such as erysipelas, cellulitis, impetigo, and soft tissue infections? Placebo or sham treatments are ineffective, and staphylocccus or streptococcus may be involved in these skin conditions.", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in treating skin diseases such as erysipelas, cellulitis, impetigo, and staphylcoccus? Additionally, what is the efficacy of placebo or sham treatment in these conditions?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in the treatment of erysipelas, cellulitis, impetigo, soft tissue infections, ignis sacer, holy fire, st anthony's fire, and skin infections, as well as Staphylocccus and Streptococcus?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in the treatment of skin diseases such as erysipelas, cellulitis, impetigo, and soft tissue infections? Additionally, what is the effectiveness of placebo or sham treatments in the control of these conditions?"]}
{"id": "27", "boolean": "(\"Tafenoquine\" [Supplementary Concept] OR Tafenoquine[tiab] OR Arakoda[tiab] OR \"WR 238605\"[tiab] OR \"WR-238605\"[tiab] OR Krintafel[tiab])AND(\"Malaria\"[Mesh] OR Malaria[tiab] OR \"Plasmodium infection\"[tiab] OR \"Plasmodium Infections\"[tiab] OR \"Remittent Fever\"[tiab] OR \"Marsh Fever\"[tiab] OR Paludism[tiab])AND(\"Pre-Exposure Prophylaxis\"[Mesh] OR \"Chemoprevention\"[Mesh] OR \"prevention and control\"[Subheading] OR Prophylaxis[tiab] OR Chemoprophylaxis[tiab] OR Prevention[tiab] OR Prevent[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What is the effectiveness of tafenoquine, Arakoda, WR 238605, or Krintafel in preventing malaria caused by Plasmodium infection, as well as related symptoms such as remittent fever, marsh fever, paludism, and placebo or drug therapy, as compared to randomized controlled trials or controlled clinical trials?", "What is the effectiveness of Tafenoquine, Arakoda, WR 238605, or Krintafel in the prevention of malaria caused by Plasmodium infections, including remittent fever, Marsh fever, paludism, or pre-exposure prophylaxis, as evaluated by randomized controlled trials or controlled clinical trials?", "What is the effectiveness of tafenoquine or arakoda, as well as other WR 238605 or Krintafel, in preventing malaria caused by Plasmodium or in general? This includes randomized controlled trials or controlled clinical trials, as well as placebo or drug therapy, and does not involve animals.", "What are the effectiveness of pre-exposure prophylaxis and drug therapy, as compared to placebo or randomized controlled trials, in preventing malaria caused by Plasmodium infections, including in humans?", "What is the effectiveness of Tafenoquine, Arakoda, WR 238605, or Krintafel in the prevention of malaria, including Plasmodium infections, remittent fever, Marsh fever, paludism, and pre-exposure prophylaxis, as compared to placebo or drug therapy, in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of tafenoquine or arakoda, in combination with randomized controlled trials or controlled clinical trials, in preventing malaria caused by Plasmodium infection or in general? Additionally, do the trials or studies include human or animal participants?", "What are the most effective methods for preventing malaria, including tafenoquine, Arakoda, WR 238605, and Kraitnaf, as well as randomized controlled trials or controlled clinical trials, and placebo or drug therapy, in both animals and humans?", "What is the effectiveness of tafenoquine (Tafenoqine or Arakoda) or WR 238605 or Krintafel) in preventing malaria caused by Plasmodium or in general, as well as remittent fever, marsh fever, paludism, and other related symptoms, as compared to placebo or other drugs, in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of tafenoquine, arakawa, or WR 238605 in preventing malaria caused by Plasmodium or in general? Are there any randomized controlled trials or controlled clinical trials that have investigated the efficacy of tafenoquine, arakawa, or WR 238605 in reducing morbidity and mortality in both humans and animals?", "What is the effectiveness of tafenoquine, arakoda, WR 238605, or Krintafel in preventing malaria caused by Plasmodium or in general? This includes randomized controlled trials or controlled clinical trials in humans, as well as placebo or drug therapy, and the associated symptoms such as remittent fever, marsh fever, paludism, and prevention and control."]}
{"id": "11", "boolean": "((\"Anti-Infective Agents\"[Mesh] OR \"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR \"Fluoroquinolones\"[Mesh] OR \"Sulfonamides\"[Mesh] OR \"Tetracyclines\"[Mesh] OR \"Aminoglycosides\"[Mesh] OR Antimicrobials[tiab] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab] OR Quinolone[tiab]) AND (\"Homes for the Aged\"[Mesh] OR \"Old Age Homes\"[tiab] OR \"Old Age Home\"[tiab] OR \"Nursing Homes\"[Mesh] OR \"Nursing Home\"[tiab] OR \"Geriatric center\"[tiab] OR \"Geriatric centers\"[tiab] OR \"Retirement communities\"[tiab] OR \"Retirement community\"[tiab] OR \"Nonhospitalized\"[tiab] OR \"Non Hospitalized\"[tiab] OR \"Nonhospitalised\"[tiab] OR \"Non Hospitalised\"[tiab] OR \"Aged care\"[tiab] OR \"Retirement home\"[tiab] OR \"Retirement homes\"[tiab]) AND (\"Aged\"[Mesh] OR \"Elderly\"[tiab] OR Old[tiab] OR Older[tiab]) AND (\"Adverse effects\"[sh] OR \"Infections\"[Mesh] OR \"Adverse effect\"[tiab] OR \"Adverse effects\"[tiab] OR \"Adversely affect\"[tiab] OR \"Adverse event\"[tiab] OR \"Adverse events\"[tiab] OR \"Poisoning\"[tiab] OR \"Toxicity\"[tiab] OR \"Discomfort\"[tiab] OR \"Pain\"[tiab] OR \"Physiological impacts\"[tiab] OR \"Physiological impact\"[tiab] OR Mortality[tiab] OR Survival[tiab] OR \"Infection\"[tiab] OR \"Infections\"[tiab] OR \"Symptomatic\"[tiab]) AND (\"Withholding Treatment\"[Mesh] OR Placebo[Mesh] OR Placebo[tiab] OR Untreated[tiab] OR \"No therapy\"[tiab] OR \"No Treatments\"[tiab] OR \"No Treatment\"[tiab] OR ((Withholding[tiab] OR Withdrawing OR Stopping OR Ceasing[tiab] OR Discontinuation[tiab]) AND (Treatments[tiab] OR Treatment[tiab] OR Therapy[tiab]))) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Observational[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Evaluated[tiab] OR Impact[tiab] OR Analysis[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh] OR Etiology[sh] OR Effect[tiab] OR Effects[tiab] OR Affect[tiab])) OR ((Antibiotics[ti] OR Antibiotic[ti] OR Penicillin[ti] OR Penicillins[ti] OR azithromycin[ti] OR Azithromycin[ti] OR Cephalexin[ti] OR Oxacillin[ti] OR Ciprofloxacin[ti] OR Ofloxacin[ti] OR Quinolone[ti]) AND (Elderly[ti] OR Old[ti] OR Older[ti] OR Aged[ti] OR Age[ti]) AND (Impairment[ti] OR Mortality[ti] OR Harms[ti] OR Harm[ti] OR Adverse[ti] OR Survival[ti]))", "generated_query": ["What is the effectiveness of anti-infective agents, including penicillin, azithromycin, and quinolone, in reducing morbidity and mortality in elderly individuals? This is evaluated in randomized controlled trials or observational studies, and the impact of antibiotics on elderly individuals is further investigated in terms of impairment, mortality, harms, or adverse effects.", "What is the effectiveness of anti-infective agents, including penicillin and other antibiotics, in preventing adverse events or mortality in elderly individuals? This question is explored in randomized controlled trials and epidemiological studies, as well as through observation and follow-up of elderly individuals. Additionally, the impact of antibiotics on aged individuals is evaluated in terms of impairment, mortality, harm, adverse effects, and survival.", "What is the effectiveness of anti-infective agents, including beta-lactams, fluroquinolones, and aminoglycosides, in the treatment of geriatric patients? Additionally, what are the adverse effects of these treatments, as evaluated in randomized controlled trials, and how do they impact geriatric survival and infection rates?", "What is the effectiveness of antibiotics and other anti-infective agents in the treatment and management of infections or symptoms in elderly individuals, including those with adverse reactions or complications, as compared to placebo or other treatments, in reducing morbidity and mortality, as well as other related outcomes such as discomfort or pain? Additionally, are there any randomized controlled trials or controlled clinical trials that have investigated the efficacy of these interventions?", "What are the benefits and drawbacks of using anti-infective agents or antibiotics in elderly individuals? This includes randomized controlled trials or controlled clinical trials, as well as epidemiologic studies, case-control studies, cohort studies, and follow-up observations, to evaluate the effectiveness of antibiotics or anti-infectives in reducing morbidity and mortality in elderly individuals?", "What is the effectiveness of antibiotics or antibiotic interventions in the treatment of infectious conditions or symptoms, including those related to aging, mortality, and adverse effects? This includes randomized controlled trials or controlled clinical trials, as well as epidemiologic studies, case-control studies, cohort studies, follow-up, or observation, and impact or analysis of statistics or data.", "What is the effectiveness of anti-infective agents and antibiotics in the treatment and management of elderly individuals, including those with adverse effects or mortality, as compared to placebo or randomized controlled trials, in reducing morbidity and improving survival?", "What is the effectiveness of anti-infective agents, including antibiotics and placebo or other treatments, in preventing adverse events or infections in elderly individuals? This question can be evaluated through randomized controlled trials or cohort studies, and the impact of antibiotics or other treatments on impairment, mortality, or harm to the elderly should be analyzed in follow-up or observational studies.", "What is the effectiveness of anti-infective agents, including penicillin, azithromycin, and ciprofloxacin, in the treatment of elderly patients? This question is evaluated by randomized controlled trials, observational studies, and epidemiology, as well as by impact and analysis of statistics and data.", "What is the effectiveness of anti-infective agents and antibiotics in preventing or treating infections or symptoms in elderly individuals? This includes randomized controlled trials, controlled clinical trials, and follow-up observation studies, as well as statistics and data on their impact or impairment, mortality, and harm."]}
{"id": "16", "boolean": "(\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR \"Fluoroquinolones\"[Mesh] OR \"Sulfonamides\"[Mesh] OR \"Tetracyclines\"[Mesh] OR \"Aminoglycosides\"[Mesh] OR Antimicrobials[tiab] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Fluoroquinolones[tiab] OR Sulfonamides[tiab] OR Tetracyclines[tiab] OR Aminoglycosides[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Penicillins[tiab] OR Methicillin[tiab] OR ampicillin[tiab] OR azithromycin[tiab] OR Cephalexin[tiab] OR Maytansine[tiab] OR Mepartricin[tiab] OR Miocamycin[tiab] OR Natamycin[tiab] OR Nystatin[tiab] OR Oleandomycin[tiab] OR Troleandomycin[tiab] OR Oligomycins[tiab] OR Rutamycin[tiab] OR Sirolimus[tiab] OR Everolimus[tiab] OR Tacrolimus[tiab] OR Tylosin[tiab] OR Amphotericin[tiab] OR Antimycin[tiab] OR Brefeldin [tiab] OR Bryostatins [tiab] OR Candicidin[tiab] OR Epothilones[tiab] OR Erythromycin[tiab] OR Azithromycin[tiab] OR Clarithromycin[tiab] OR Ketolides[tiab] OR Roxithromycin[tiab] OR Filipin[tiab] OR Ivermectin[tiab] OR Josamycin[tiab] OR Leucomycins[tiab] OR Kitasamycin[tiab] OR Spiramycin[tiab] OR Carbapenems[tiab] OR Thienamycins[tiab] OR Cephalosporins[tiab] OR Cefamandole[tiab] OR Cefazolin[tiab] OR Cefonicid[tiab] OR Cefsulodin[tiab] OR Cephacetrile[tiab] OR Cephalexin[tiab] OR Cephaloridine[tiab] OR Cephamycins[tiab] OR Clavulanic[tiab] OR Monobactams[tiab] OR Aztreonam[tiab] OR Moxalactam[tiab] OR Amdinocillin[tiab] OR Cyclacillin[tiab] OR Methicillin[tiab] OR Nafcillin[tiab] OR Oxacillin[tiab] OR Penicillanic[tiab] OR Sulbactam[tiab] OR Ticarcillin[tiab] OR Amoxicillin[tiab] OR Ciprofloxacin[tiab] OR Fleroxacin[tiab] OR Enoxacin[tiab] OR Norfloxacin[tiab] OR Ofloxacin[tiab] OR Levofloxacin[tiab] OR Pefloxacin[tiab]) AND (Erysipelas[Mesh] OR Erysipelas[tiab] OR \"Skin Diseases, Infectious\"[Mesh] OR Cellulitis[Mesh] OR Cellulitis[tiab] OR Impetigo[tiab] OR Impetigo[Mesh] OR \"Soft Tissue Infections\"[Mesh] OR \"Holy fire\"[tiab] OR \"st anthony's fire\"[tiab] OR \"Soft Tissue Infections\"[tiab] OR \"Soft Tissue Infection\"[tiab] OR \"Skin infections\"[tiab] OR \"Skin infection\"[tiab] OR ((Staphylococcus[Mesh] OR staphylococcus[tiab] OR Streptococcus[Mesh] OR streptococcus[tiab]) AND (Skin[Mesh] OR Skin[tiab]))) AND (\"Administration, Oral\"[Mesh] OR Oral[tiab] OR Orally[tiab]) AND (\"Infusions, Parenteral\"[Mesh] OR \"Injections, Intravenous\"[Mesh] OR Intravenous[tiab] OR Intravenously[tiab] OR IV[tiab] OR parenteral[tiab] OR parenterally[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT (Animals[Mesh] NOT (Animals[Mesh] AND Humans[Mesh]))", "generated_query": ["What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and antimicrobials, in treating skin diseases such as erysipelas, cellulitis, impetigo, and staphyloccoccal infections? Additionally, what are the benefits of oral infusions or intravenous injections of randomized controlled trials or controlled clinical trials, as compared to placebo or drug therapy, in the diagnosis and management of these conditions? Finally, what is the effectiveness of anti-bacterial agents in treating human skin infections?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, and tetracyclines, in the treatment of skin conditions such as erysipelas, cellulitis, impetigo, and soft tissue infections? Additionally, do oral infusions or intravenous injections of randomized controlled trials or controlled clinical trials provide a placebo or drug therapy to human and animal patients?", "What is the effectiveness of anti-bacterial agents and parenteral infusions or intravenous injections of fluoroquinolones, aminoglycosides, and tetracyclines in the treatment of erysipelas, cellulitis, impetigo, and soft tissue infections? Additionally, do these drugs have any randomized controlled trials or controlled clinical trials that have investigated their efficacy?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, and tetracyclines, in the treatment of infectious skin diseases, including cellulitis, impetigo, and soft tissue infections, as well as staphylocccus and streptococcus, and how do they compare to placebo or randomized controlled trials or controlled clinical trials?", "What is the effectiveness of anti-bacterial agents, including Macrolides, Beta-lactams, Fluoroquinolones, Sulfonamides, Tetracyclines, Aminoglycosides, Antimicrobials, Penicillin, Methicillin, ampicillin, azithromycin, clarithromycin, Ketolides, Roxithromycin, Filipin, Ivermectin, Josamycin, Leucomycins, Kitasamycin, Spiramycin, Carbapenems, Thienamycins, Cephalosporins, Cefamandole, Cefazolin, Cefonicid, Cefsulodin, Cephaloridine, Cephaloidin, Clavulanic, Monobactams, Aztreonam, Moxalactam, Amdinocillin, Cyclacillin, Methicillin, Nafcillin, Ofloxacin, Levofloxacin, Pefloxacin), and oral or parenteral intervent", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, Aminoglycosides, and antimicrobials, in the treatment of skin diseases such as impetigo, cellulitis, and staphyloccocus infections? Additionally, what is the efficacy of oral infusions or intravenous injections of randomized controlled trials or controlled clinical trials in the context of animal-human comparison studies?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and antimicrobials, in the treatment of skin diseases such as impetigo, cellulitis, st anthony's fire, soft tissue infections, and streptococcal infections?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, flouroquinolones, sulfonamides, tetracyclines, aminoglycosides, and antimicrobials, in the treatment of skin diseases such as impetigo, eczema, and cellulitis? Additionally, what is the effectiveness of oral infusions and parenteral injections of randomized controlled trials or controlled clinical trials?", "What is the effectiveness of anti-bacterial agents, including macrolides, fluoroquinolones, sulfonamides, and tetracyclines, in the treatment of skin diseases such as erysipelas, cellulitis, impetigo, and soft tissue infections? Additionally, what is the effectiveness of oral infusions and intravenous injections of these drugs, as well as randomized controlled trials or controlled clinical trials, in the treatment of skin conditions? Finally, do these drugs have any effectiveness in the treatment of bacterial infections?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, fluoroquinolones, sulfonamides, tetracyclines, aminoglycosides, and antimicrobials, in treating skin diseases such as erysipelas, cellulitis, impetigo, and staphylocccus? Additionally, what is the effectiveness of oral and parenteral drug therapy, as compared to placebo or randomized controlled trials, in the treatment of these conditions?"]}
{"id": "15", "boolean": "((\"Influenza, Human\"[Mesh] OR Influenza[tiab] OR \"Respiratory viruses\"[tiab]) AND (Schools[Mesh] OR School[tiab] OR Schools[tiab] OR ((Children[tiab]) AND (Community)) OR ((\"Young Adult\"[Mesh] OR \"Adolescent\"[Mesh] OR Child[Mesh] OR Infant[Mesh]) AND (\"Population Surveillance\"[Mesh] OR Pandemics[Mesh] OR Pandemic[tiab] OR Pandemics[tiab]))) AND (\"Absenteeism\"[Mesh] OR Closure[tiab] OR Closures[tiab] OR Closed[tiab] OR Vacation[tiab] OR Holiday[tiab] OR Holidays[tiab] OR Outbreak[tiab] OR Outbreaks[tiab] OR Dismissed[tiab] OR Epidemiological[tiab] OR Surveillance[tiab]) AND (Incidence[Mesh] OR Morbidity[Mesh] OR \"Population Surveillance\"[Mesh] OR \"Disease Notification\"[Mesh] OR \"Disease Outbreaks\"[Mesh] OR Incidence[tiab] OR Morbidity[tiab] OR Mortality[tiab] OR Case[tiab] OR Cases[tiab]) AND (\"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR retrospective[tiab] OR \"cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]))", "generated_query": ["What is the effectiveness of school closure or vacation, or other interventions, in reducing morbidity or mortality in children or adolescents in the event of an influenza pandemic or outbreak, as well as the associated symptoms such as fever, cough, sore throat, and runny nose?", "What is the effectiveness of influenza prevention measures, including school closures and vaccines, in reducing morbidity and mortality in children and adolescents, as well as population surveillance and epidemiological studies, during the pandemic?", "What is the effectiveness of influenza surveillance and prevention in schools, including children, adolescents, infants, and young adults, as compared to placebo or other interventions, in reducing morbidity and mortality in both children and adults? Additionally, what is the effectiveness of epidemiological studies, including case-control studies, cohort studies, and retrospective studies, in identifying risk factors for influenza and other respiratory viruses, as well as the association between influenza and absenteeism or school closure, and how do these studies compare to placebo or other interventions?", "What is the association between influenza and school closures or outbreaks, as well as the development or progression of disease, in children and adolescents, and how do epidemiological studies investigate the effectiveness of school-based surveillance and population notification systems in detecting and preventing morbidity and mortality in both children and adolescents?", "What is the effectiveness of influenza vaccines in preventing influenza, human respiratory viruses, and related diseases such as pneumonia and bronchitis? This includes studies on the morbidity and mortality of these diseases, as well as the incidence and prevalence of influenza, and the duration of symptoms such as coughing, shortness of breath, and fever. Additionally, how do vaccines impact population surveillance and disease notification, and how do they compare to placebo or other treatments, including antibiotics and vaccines for other illnesses?", "What is the association between influenza, including respiratory viruses, and absenteeism or school closure in children, adolescents, and infants, as well as the incidence and morbidity of pandemic and endemic strains, and how do epidemiologic studies investigate and analyze the data?", "What is the effectiveness of schools, including those for children, adolescents, and infants, in the detection and surveillance of influenza and related respiratory viruses, as well as their associated symptoms such as absenteeism, closure, and vacation, and how do they compare to epidemiologic studies and case-control studies?", "What is the effectiveness of influenza vaccines in reducing morbidity and mortality in children and adolescents, as compared to placebo or other interventions, in preventing influenza and respiratory viruses, including H1N1, H3N2, and B strains, in schools? Additionally, what is the effectiveness of influenza vaccines in detecting and surveilling for outbreaks or epidemics, as compared to placebo or other interventions, in children and adolescents, and what is the statistical and numerical data to support this?", "What is the impact of influenza, including human and respiratory viruses, on school absenteeism and closures, as well as children and adolescents in the school population, and how do these factors affect the epidemiological and surveillance studies of the disease?", "What is the association between influenza, human respiratory viruses, and school absenteeism or closures, as well as epidemiological studies and statistics, in cases where children, adolescents, and young adults are surveyed?"]}
{"id": "39", "boolean": "(\"Urinary Bladder, Underactive\"[Mesh] OR \"Urinary Retention\"[Mesh] OR \"Urodynamics\"[Mesh] OR \"Residual urine\"[tiab] OR \"Urinary retention\"[tiab] OR \"Urodynamic study\"[tiab] OR \"Urodynamic parameters\"[tiab] OR ((Underactive[tiab] OR Underactivity[tiab] OR Hypotonic[tiab] OR Acontractile[tiab] OR hypocontractility[tiab] OR Failure[tiab] OR Areflexia[tiab] OR Atonic[tiab] Impaired[tiab] OR Dysfunction[tiab]) AND (Bladder[tiab] OR Bladders[tiab] OR Detrusor[tiab] OR Detrusors[tiab]))) AND (\"Parasympathomimetics\"[Mesh] OR \"Parasympathomimetics\"[Pharmacological Action] OR  \"Receptors, Muscarinic\"[Mesh] OR \"Bethanechol\"[Mesh] OR \"Bethanechol Compounds\"[Mesh] OR \"Carbachol\"[Mesh] OR \"Diazepam\"[Mesh] OR \"Cisapride\"[Mesh] OR \"Phenoxybenzamine\"[Mesh] OR \"Dinoprost\"[Mesh] OR \"Neostigmine\"[Mesh] OR Parasympathomimetics[tiab] OR Parasympathomimetic[tiab] OR Muscarinic[tiab] OR Bethanechol[tiab] OR Bethanecol[tiab] OR Duvoid[tiab] OR Myotonine[tiab] OR Myocholine[tiab] OR PMS-Bethanechol[tiab] OR Urocarb[tiab] OR Myotonachol[tiab] OR Urecholine[tiab] OR Carbachol[tiab] OR Diazepam[tiab] OR Alfusozine[tiab] OR \"Cisapride\"[tiab] OR \"Distigmine bromide\"[tiab] OR Phenoxybenzamine[tiab] OR Prostaglandin[tiab] OR \"Neostigmine\"[tiab] OR (Myo[tiab] AND Hermes[tiab])) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR Report[ti]) NOT  (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh]))", "generated_query": ["What is the effectiveness of urinary bladder underactivity or urinary retention, as well as the related urodynamic parameters and symptoms, and how do parasympathomimetics or pharmacological action of receptors, muscarinic, affect them? Additionally, does the use of randomized controlled trials or controlled clinical trials in conjunction with placebo or drug therapy in humans provide any insights into the effectiveness of these treatments?", "What is the effectiveness of parasympathomimetics, including bethanechol, carbachol, diazepam, cisapride, phenoxybenzamine, and neostigmine, in treating urinary bladder underactivity, urinary retention, or urodynamic study? Additionally, do randomized controlled trials or controlled clinical trials have any effectiveness in managing these conditions?", "What are the most effective urinary bladder treatments for patients with underactive bladder, urinary retention, urodynamics, residual urine, urodynamic study, or urodynamic parameters, including those related to bladder and detrusor function, and how do they compare to placebo or drug therapy, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of using parasympathomimetics or pharmacological action of receptors, muscarinic, to treat urinary bladder conditions such as underactive bladder, urinary retention, urodynamics, and residual urine? Additionally, what is the effectiveness of drug therapy or randomized controlled trials or controlled clinical trials in treating these conditions?", "What is the effectiveness of parasympathomimetics and related compounds in the diagnosis and management of urinary bladder underactivity or retention, as well as urinary retirement, and how do they compare to placebo or other interventions, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of parasympathetic drugs, including bethanechol, carbachol, and phenoxybenzamine, in treating urinary bladder conditions such as underactivity, retention, and dysfunction?", "What is the effectiveness of urinary bladder parasympathomimetics and urodynamic studies in the diagnosis and management of urinary retention, urodynamic parameters, and residual urine, as well as randomized controlled trials or controlled clinical trials, and placebo or drug therapy, in conjunction with animal studies?", "What is the effectiveness of urinary bladder underactive or retention, as well as other urinary dynamics and related conditions, including residual urine and urodynamic study, and how do parasympathomimetics and related compounds interact with these conditions? Additionally, are there any randomized controlled trials or controlled clinical trials that have investigated their efficacy?", "What is the effectiveness of urinary bladder management techniques involving parasympathomimetics or drug therapy, as compared to placebo or other treatments, in improving urodynamic parameters and clinical outcomes in patients with underactive bladder or urinary retention, as well as in patients with conditions related to urinary bladder function, including but not limited to detrusor hypoactivity, hypotonia, acontractility, failure, atonia, impairment, and dysfunction?", "What is the effectiveness of urinary bladder parasympathomimetics or sympathetic agents, including bethanechol, carbachol, diazepam, cisapride, and phenoxybenzamine, in treating underactive bladder conditions or urinary retention, as well as other related symptoms such as dysuria or frequency of urination, and how do randomized controlled trials or controlled clinical trials have to do with this?"]}
{"id": "78", "boolean": "(\"Drug Resistance, Microbial\"[Mesh] OR \"Drug resistance\"[tiab] OR \"Drug resistant\"[tiab] OR \"multidrug-resistant\"[tiab] OR \"multidrug resistant\"[tiab] OR \"Microbial resistant\"[tiab] OR \"Microbial resistance\"[tiab] OR \"Antibiotic resistance\"[tiab] OR \"Antibiotic resistant\"[tiab] OR \"Antibacterial resistance\"[tiab] OR \"Antibacterial resistant\"[tiab] OR \"Antimicrobial resistance\"[tiab] OR \"Antimicrobial resistant\"[tiab]) AND (\"Anti-Bacterial Agents\"[Mesh] OR \"Macrolides\"[Mesh] OR \"beta-Lactams\"[Mesh] OR Antibacterial[tiab] OR Antibacterials[tiab] OR Antibiotics[tiab] OR Antibiotic[tiab] OR Macrolides[tiab] OR Macrolide[tiab] OR beta-Lactams[tiab] OR Antimicrobial[tiab] OR Antimicrobials[tiab] OR Penicillin[tiab] OR Methicillin[tiab] OR Ampicillin[tiab] OR Azithromycin[tiab] OR Cephalexin[tiab] OR Apramycin[tiab] OR Streptomycin[tiab]) AND (\"Cattle\"[Mesh] OR \"Swine\"[Mesh] OR \"Poultry\"[Mesh] OR \"Farm animals\"[tiab] OR \"Food animals\"[tiab] OR Cattle[tiab] OR Beef[tiab] OR Swine[tiab] OR Pig[tiab] OR Pigs[tiab] OR Poultry[tiab] OR Chickens[tiab]) AND (\"Systematic review\"[tiab] OR \"Meta-analysis\"[tiab] OR Randomised[tiab] OR Randomized[tiab] OR Randomise[tiab] OR Randomize[tiab] OR Randomly[tiab] OR Controlled[tiab] OR \"Control group\"[tiab] OR Epidemiology[sh] OR \"Morbidity\"[Mesh] OR Comparison[tiab] OR Compared[tiab] OR Compare[tiab] OR Examined[tiab] OR Observations[tiab] OR Observed[tiab] OR Longitudinal[tiab] OR Experimental[tiab] OR Experiments[tiab] OR Investigate[tiab] OR (Before[tiab] AND After[tiab])) AND (\"Microbial Sensitivity Tests\"[Mesh] OR Isolates[tiab] OR Isolated[tiab] OR Samples[tiab] OR Strains[tiab] OR Strain[tiab] OR Carriage[tiab] OR Phylogenetic OR Metagenomic OR PCR) AND (\"Zoonoses\"[Mesh] OR \"Animal Diseases\"[Mesh] OR Zoonoses[tiab] OR Transmitted[tiab] OR Transmission[tiab] OR Susceptibility[tiab] OR Susceptible[tiab] OR Selective[tiab] OR Selection[tiab]) AND (\"Humans\"[Mesh] OR Humans[tiab] OR Human[tiab] OR Farmer[tiab] OR Farmers[tiab] OR \"Farm worker\"[tiab] OR \"Farm workers\"[tiab])", "generated_query": ["What is the effectiveness of drug resistance screening techniques in identifying and monitoring microbial sensitivity to antibiotic agents, including Macrolides, beta-lactams, and other anti-bacterial agents, in order to prevent zoonoses or animal diseases, as well as transmitted and selected resistance, in humans?", "What is the effectiveness of drug resistance and microbial sensitivity tests in detecting and monitoring the spread of drug-resistant strains of bacteria, including Escherichia coli and Staphyloccocus aureus, in animals and humans?", "What is the effectiveness of using drug resistance tests and microbial sensitivity tests to detect zoonotic or animal diseases in humans, and how do these tests compare to each other in terms of accuracy and reliability?", "What is the effectiveness of drug resistance and anti-bacterial agents in the prevention and treatment of microbial infections or bacterial diseases, including those caused by Escherichia coli and Staphylococcus aureus, in humans, animals, and food animals?", "What is the effectiveness of using microbial sensitivity tests and human disease surveillance to detect and monitor drug resistance in animals and humans, as well as their associated bacteria, and how do the results compare to each other?", "What is the effectiveness of using drug resistance and sensitivity tests to detect and monitor the development of zoonotic and animal diseases, including bovine, swine, poultry, and food animal morbidity and mortality, as well as human diseases such as tuberculosis? Additionally, what is the effectiveness of using these tests to detect and monitor the development of drug resistant strains and species, and how do they compare to placebo or other treatments, including anti-bacterial agents, in reducing morbidity and mortality in humans and animals?", "What is the effectiveness of anti-bacterial agents and microbial sensitivity tests in the diagnosis and management of zoonoses, animal diseases, and transmission of pathogenic organisms to humans?", "What is the effectiveness of anti-bacterial agents and microbial sensitivity tests in detecting and monitoring drug resistance in bacterial populations, including those in food animals and humans, and how do these tests compare to placebo or other interventions in preventing zoonoses or animal diseases?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and antibiotics, in preventing microbial resistance to antibiotics, as compared to placebo or other interventions, in cattle, swine, poultry, farm animals, and food animals?", "What is the effectiveness of anti-bacterial agents, including macrolides, beta-lactams, and streptomycin, in the diagnosis and management of bovine and porcine infectious diseases, including zoonoses and human diseases, caused by Mycoplasma, bacteria, and fungi?"]}
{"id": "88", "boolean": "(\"Patient Education as Topic\"[Mesh] OR \"Self Care\"[Mesh] OR \"Behavior Therapy\"[Mesh] OR \"Group Processes\"[Mesh] OR \"Psychotherapy, Group\"[Mesh] OR \"Self-Help Groups\"[Mesh] OR Patient education[tiab] OR Self care[tiab] OR Self management[tiab] OR Behavior therapy[tiab] OR Behaviour therapy[tiab] OR Group process[tiab] OR Group processes[tiab] OR Group psychotherapy[tiab] OR ((Education[tiab] OR Educational[tiab] OR psychoeducational[tiab] OR Training[tiab] OR Teaching[tiab] OR Lifestyle[tiab]) AND (Programme[tiab] OR Programmes[tiab] OR Program[tiab] OR Programs[tiab]))) AND (\"Diabetes Mellitus, Type 2\"[Mesh] OR MODY[tiab] OR NIDDM[tiab] OR T2DM[tiab] OR ((non insulin[tiab] OR noninsulin[tiab] OR \"Type 2\"[tiab] OR \"Type II\"[tiab] OR Ketosis-Resistant[tiab] OR Ketosis resistant[tiab] OR Maturity-Onset[tiab] OR Maturity onset[tiab] OR Mature-onset[tiab] OR Mature onset[tiab] OR Adult-onset[tiab] OR Adult onset[tiab] OR Slow-onset[tiab] OR Slow onset[tiab] OR Stable[tiab]) AND Diabetes)) AND (Group[tiab] OR Groups[tiab] OR Participants[tiab]) NOT (\"Diabetes Insipidus\"[Mesh] OR Diabetes Insipidus[tiab]) AND (randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[MeSH Terms] OR randomly[tiab] OR groups[tiab] OR Controlled[tiab] OR Control[tiab] OR Trial[tiab] OR Trials[tiab] OR Blind[tiab] OR Blinded[tiab] OR Volunteer[tiab] OR Volunteers[tiab]) NOT (animals[Mesh] NOT humans[Mesh])", "generated_query": ["What is the effectiveness of patient education, self care, behavior therapy, group processes, psychotherapy, and diabetes management programs for patients with type 2 diabetes? Additionally, are there any randomized controlled trials or controlled clinical trials that have investigated their efficacy?", "What is the effectiveness of patient education, behavior therapy, and group processes in the treatment of diabetic patients? This includes randomized controlled trials or controlled clinical trials, as well as placebo or drug therapy, and may be blinded or randomized. Additionally, does the intervention have an impact on diabetic patients with maturity onset or adulthood?", "What is the effectiveness of patient education and behavior therapy, as well as group processes and psychotherapy, in managing diabetes mellitus, type 2, and its related conditions, including NIDDM, T2DM, and non-insulin therapy?", "What is the effectiveness of patient education and behavior therapy in the self-management of diabetes mellitus, including Mini-Hyperglycemia (MODY), NIDDM, T2DM, and related conditions, as well as randomized controlled trials and controlled clinical trials?", "What are the most effective patient education and behavior therapy interventions for diabetes mellitus, including programs and group processes, as compared to placebo or drug therapy, in improving the self-management and behavioral outcomes of patients with type 2 diabetes?", "What are the most effective patient education and self-care programs for managing type 2 diabetes mellitus, including those related to MODY, NIDDM, T2DM, and the associated complications such as blindness, maturity onset, and behavior therapy, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of patient education, self care, behavior therapy, group processes, psychotherapy, group psychotherapy, and randomized controlled trials or controlled clinical trials in the diagnosis and management of diabetes mellitus, type 2, or related disorders?", "What is the effectiveness of patient education and group processes in the management of diabetic mellitus, including MODY, NIDDM, T2DM, and related complications? This includes studies on the topics of behavior therapy, group psychotherapy, and self-help groups, as well as randomized controlled trials and controlled clinical trials, and placebo or drug therapy. Additionally, does patient education and group processes improve diabetic mellitus in patients with randomized controlled trials or controlled clinical trials? Finally, do animals have any effectiveness in the management of diabetic mellitus?", "What are the effects of patient education, self care, and behavior therapy in the management of diabetes mellitus, type 2, including MODY, NIDDM, and T2DM, as well as related conditions such as ketosis-resistant and maturity-onset diabetes, and how do they compare to placebo or drug therapy, as evaluated in randomized controlled trials or controlled clinical trials?", "What are the most effective patient education programs or self-care techniques for type 2 diabetes mellitus, including those with MODY or NIDDM, as compared to placebo or drug therapy, in reducing morbidity and mortality in both adults and children? This research should be conducted in randomized controlled trials or controlled clinical trials, and should include participation of both groups and individuals."]}
{"id": "4", "boolean": "((\"COVID-19\"[Supplementary Concept] OR \"COVID-19\"[tiab] OR COVID19[tiab] OR \"COVID 19\"[tiab] OR \"SARS-CoV-2\"[tiab] OR \"2019-nCoV\"[tiab] OR \"Novel coronavirus\"[tiab] OR \"Coronavirus 2019\"[tiab] OR \"Coronavirus 19\"[tiab] OR \"COVID 2019\"[tiab] OR \"2019 ncov\"[tiab] OR \"Wuhan coronavirus\"[tiab])  AND (\"Asymptomatic Diseases\"[Mesh] OR Asymptomatic[tiab] OR Presymptomatic[tiab] OR \"Pre-Symptomatic\"[tiab] OR \"No symptoms\"[tiab] OR \"No symptom\"[tiab] OR \"Silent transmission\"[tiab] OR \"Silent carrier\"[tiab] OR \"Silent carriers\"[tiab]) AND (Letter[pt] OR \"Epidemiologic Studies\"[Mesh] OR \"Case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"Case control\"[tiab] OR Longitudinal[tiab] OR Prospective[tiab] OR Retrospective[tiab] OR \"Cross sectional\"[tiab] OR \"Cross-Sectional Studies\"[Mesh] OR Investigated[tiab] OR Analysis[tiab] OR Data[tiab] OR Cases[tiab] OR Ratio[tiab] OR \"statistics and numerical data\"[sh] OR \"epidemiology\"[sh]) ) OR ( (\"COVID-19\"[ti] OR COVID19[ti] OR \"COVID 19\"[ti] OR \"SARS-CoV-2\"[ti] OR \"2019-nCoV\"[ti] OR \"Novel coronavirus\"[ti] OR \"Coronavirus 2019\"[ti] OR \"Coronavirus 19\"[ti] OR \"COVID 2019\"[ti] OR \"2019 ncov\"[ti] OR \"Wuhan coronavirus\"[ti]) AND (Asymptomatic[ti] OR Presymptomatic[ti] OR \"Pre-Symptomatic\"[ti]))", "generated_query": ["What is the effectiveness of interventions for COVID-19, including antivirals and vaccines, in reducing morbidity and mortality in both adults and children, as well as in individuals with and without symptoms?", "What is the effectiveness of interventions for COVID-19, including vaccines and antivirals, in reducing morbidity and mortality in both children and adults? Specifically, what is the effectiveness of these interventions in individuals with asymptomatic or pre-symptomatic disease?", "What are the benefits of treating COVID-19 or SARS-CoV-2 as an asymptomatic or presymptomatic condition, and what are the implications of such treatment on epidemiologic studies or case-control studies?", "What is the effectiveness of screening methods for detecting coronavirus disease (COVID-19) or novel coronavirus (2019-nCoV) in individuals with asymptomatic or presymptomatic conditions?", "What is the effectiveness of interventions for COVID-19, including antivirals and vaccines, for reducing morbidity and mortality in both children and adults?", "What is the effectiveness of interventions for COVID-19, including antibiotics and vaccines, compared to placebo or other treatments, in reducing morbidity and mortality in both children and adults?", "What is the effectiveness of screening methods for detecting and monitoring the spread of COVID-19, including SARS-CoV-2, 2019-nCoV, and Novel Coronavirus, in patients with asymptomatic or presymptomatic conditions?", "What is the effectiveness of interventions for coronavirus infections, including antiviral drugs and vaccines, in reducing morbidity and mortality in both children and adults?", "What is the effectiveness of screening for detecting coronavirus 2019, including inhibitors and antibodies, in patients with asymptomatic or presymptomatic conditions? This includes the analysis of epidemiologic studies, case-control studies, cohort studies, and follow-up studies. Additionally, what is the ratio of infected patients to those with symptoms, and what is the transmission and carriage rate of the virus?", "What is the effectiveness of interventions for COVID-19, including antivirals and vaccines, in reducing morbidity and mortality in both symptomatic and asymptomatic individuals?"]}
{"id": "10", "boolean": "(\"Gastroesophageal Reflux\"[Mesh] OR \"Esophagitis\"[Mesh] OR \"Heartburn\"[Mesh] OR \"Dyspepsia\"[Mesh] OR \"Duodenogastric Reflux\"[Mesh] OR Reflux[tiab] OR GERD[tiab] OR Oesophagitis[tiab] OR Esophagitis[tiab] OR Heartburn[tiab] OR \"Heart burn\"[tiab] OR GORD[tiab] OR Dyspepsia[tiab] OR Dyspepsias[tiab] OR Indigestion[tiab] OR Indigestions[tiab]) AND (\"Sleep\"[Mesh] OR Sleep[tiab] OR Sleeping[tiab] OR Bed[tiab] OR Bed-Head[tiab] OR Bed-up[tiab] OR Bedrest[tiab] OR Bed-rest[tiab] OR Nocturnal[tiab] OR Wedge[tiab]) AND (\"Patient Positioning\"[Mesh] OR \"Supine Position\"[Mesh] OR Positioning[tiab] OR Position[tiab] OR Supine[tiab] OR Elevation[tiab] OR Elevated OR Raised[tiab] OR Semi-recumbent[tiab] OR Semireclined[tiab] OR Semi-reclined[tiab] OR \"Semi reclined\"[tiab] OR Left-side[tiab] OR Right-side[tiab] OR Side[tiab] OR Lateral[tiab])", "generated_query": ["What is the effectiveness of patient positioning and sleep hygiene interventions in reducing gastroesophageal reflux and related symptoms such as heartburn, dyspepsia, and duodenogastric reflux? This includes studies on gastroesophageal reflux disease (GERD), esophagitis, and related conditions such as sleep deprivation and positional changes.", "What is the effectiveness of sleep positioning and patient positioning in the treatment of gastroesophageal reflux, including symptoms such as heartburn, dyspepsia, and duodenogastric reflux?", "What is the effectiveness of sleep positioning and patient positioning techniques in managing gastroesophageal reflux and related symptoms, including heartburn, dyspepsia, and duodenogastric reflux, as well as other conditions such as esophagitis, emesis, and regurgitation?", "What is the effectiveness of patient positioning and sleep hygiene interventions in improving gastroesophageal reflux and related symptoms such as esophagitis, heartburn, dyspepsia, duodenogastric reflux, and sleep disturbances? Specifically, I am interested in studies that utilize positioning techniques such as those described above.", "What is the effectiveness of patient positioning and sleep habits in treating gastroesophageal reflux, esophagitis, heartburn, dyspepsia, duodenogastric reflux, reflux, gerd, oesophagitis, esophagertic, heartburn, \"heart burn\", gord, dyspepsia, dyspepsias, indigestion, and positioning of the bed or head to improve sleep?", "What is the effectiveness of gastroesophageal reflux treatments that involve sleep positioning or patient positioning, including supine, elevation, and lateral sleep positions?", "What is the effectiveness of patient positioning and sleep hygiene interventions for gastroesophageal reflux, including GERD, heartburn, dyspepsia, duodenogastric reflux, and reflux?", "What is the effectiveness of sleep positioning and patient positioning in the diagnosis and management of gastroesophageal reflux, esophagitis, heartburn, dyspepsia, duodenogastric reflux, reflux, GERD, Oesophagitis, Esophagitis, Heartburn, \"Heart burn\", GORD, Dyspepsia, Dyspepsias, Indigestion, and indigestions?", "What is the effectiveness of patient positioning and sleeping habits in the diagnosis and management of gastroesophageal reflux and related conditions, including dyspepsia, duodenogastric reflux, and reflux-induced esophagitis?", "What is the effectiveness of patient positioning and sleep hygiene interventions for the management of gastroesophageal reflux, including heartburn, dyspepsia, and gastric ulcers, as well as related conditions such as emesis, regurgitation, and difficulty swallowing? Specifically, how do changes in sleep position affect the development or progression of these symptoms?"]}
{"id": "32", "boolean": "(\"Telemedicine\"[Mesh] OR \"Videoconferencing\"[Mesh] OR Telehealth[tiab] OR Telemedicine[tiab] OR Videoconferencing[tiab] OR ((Telephone[tiab]) AND (Consultation[tiab] OR face-to-face[tiab] OR in-person[tiab])) OR telephone-delivered[tiab]) AND (\"Primary Health Care\"[Mesh] OR \"General Practice\"[Mesh] OR rehabilitation[sh] OR \"Outpatients\"[Mesh] OR \"Speech Therapy\"[Mesh] OR Outpatient[tiab] OR \u201cPrimary health\u201d[tiab] OR \u201cPrimary care\u201d[tiab] OR \u201cGeneral practice\u201d[tiab] OR \u201cGeneral practices\u201d[tiab] OR \u201cGeneral practitioners\u201d[tiab] OR \u201cGeneral practitioner\u201d[tiab] OR \u201cFamily practice\u201d[tiab] OR Physician[tiab] OR Physicians[tiab] OR Clinician[tiab] OR Clinicians[tiab] OR Therapist[tiab] OR Nurse[tiab] OR Nurses[tiab] OR Physiotherapist[tiab] OR Rehabilitation[tiab] OR Diabetes[tiab] OR Diabetic[tiab] OR Asthma[tiab] OR Depression[tiab] OR \u201c\u00cfrritable bowel\u201d[tiab] OR IBS[tiab] OR PTSD[tiab] OR \u201cChronic fatigue\u201d[tiab]) AND ((Face to face[tiab]) OR \u201cUsual care\u201d[tiab] OR Visits[tiab] OR Visit[tiab] OR In-person[tiab] OR \u201cIn person\u201d[tiab] OR ((Clinic[tiab] OR Centre[tiab] OR Home[tiab]) AND (Based[tiab] OR Contact[tiab])) OR Conventional[tiab] OR \u201cPractice-based\u201d[tiab] OR \u201cPractice based\u201d[tiab] OR Traditional[tiab] OR \u201cStandard care\u201d[tiab] OR Homecare[tiab] OR ((Routine[tiab] OR Home[tiab]) AND (Care[tiab]))) AND (\"Delivery of Health Care\"[Mesh] OR Delivery[tiab] OR Delivered[tiab] OR Via[tiab] OR Received[tiab]) AND (\"Treatment Outcome\"[Mesh] OR \"Patient Satisfaction\"[Mesh] OR Therapy[sh] OR Diagnosis[sh] OR \u201cClinical outcomes\u201d[tiab] OR Treatment[tiab] OR Diagnostic[tiab] OR Efficacy[tiab]) AND (Randomized controlled trial[pt] OR controlled clinical trial[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR \"drug therapy\"[sh] OR randomly[tiab] OR trial[tiab] OR groups[tiab]) NOT  (Animals[Mesh] not (Animals[Mesh] and Humans[Mesh])) NOT (\u201cCase Reports\u201d[pt] OR Editorial[pt] OR Letter[pt] OR Meta-Analysis[pt] OR \u201cObservational Study\u201d[pt] OR \u201cSystematic Review\u201d[pt] OR \u201cCase Report\u201d[ti] OR \u201cCase series\u201d[ti] OR Meta-Analysis[ti] OR \u201cMeta Analysis\u201d[ti] OR \u201cSystematic Review\u201d[ti] OR \u201cSystematic Literature Review\u201d[ti] OR \u201cQualitative study\u201d[ti] OR Protocol[ti]) ", "generated_query": ["What is the effectiveness of telemedicine, videoconferencing, and telehealth in the delivery of primary health care, including rehabilitation and outpatient services, and how do these technologies impact treatment outcome and patient satisfaction?", "What is the effectiveness of telemedicine, videoconferencing, and telehealth in the delivery of healthcare and treatment outcome, as evaluated by randomized controlled trials or controlled clinical trials, and involving patients with primary health care needs, including rehabilitation, outpatients, and speech therapy? Additionally, what are the clinical outcomes of telemedicine, including diabetes, asthma, depression, and other related conditions, as evaluated by case reports or editorials, and involving patients with primary health care needs? Finally, what is the impact of telemedicine on the delivery of healthcare, as evaluated by systematic reviews or protocols, and involving patients with primary health care needs?", "What is the effectiveness of telemedicine and videoconferencing in the delivery of primary health care, including general practice, rehabilitation, outpatients, speech therapy, and family practice, as well as clinical outcomes and diagnostic accuracy, as compared to placebo or drug therapy, in treating chronic fatigue, diabetic retinopathy, and other conditions?", "What is the effectiveness of telemedicine, videoconferencing, and rehabilitation therapy in the delivery of primary health care, including family practice, and treatment outcome for patients with chronic fatigue, depression, or PTSD? Additionally, what is the effectiveness of telemedicine and rehabilitation therapy in diagnosing and managing diabetes, asthma, and other related conditions?", "What is the effectiveness of telemedicine, videoconferencing, and other forms of healthcare delivery and diagnostic accuracy, as compared to in-person care, in the treatment of primary healthcare patients with rehabilitative needs, including those with diabetes, asthma, depression, and chronic fatigue? Additionally, what is the effectiveness of telehealth-based clinical trials and randomized controlled trials in the diagnosis and treatment of primary healthcare patients?", "What are the most effective delivery methods and treatment outcomes for telemedicine and videoconferencing, including primary health care, general practice, rehabilitation, outpatients, speech therapy, outpatient, \u201cprimary health\u201d, \u201cprimary care\u201d, \u201cgeneral practice\u201d, \u201cgeneral practitioners\u201d, \u201cgeneral practitioner\u201d, \u201cfamily practice\u201d, and physicians, for the diagnosis and management of chronic conditions such as diabetes, asthma, depression, irritable bowel syndrome, and PTSD? Additionally, what are the most effective delivery methods and treatment outcomes for telemedicine and videoconferencing, including primary health care, general practice, rehabilitation, outpatients, speech therapy, outpatient, \u201cprimary health\u201d, \u201cprimary care\u201d, \u201cgeneral practice\u201d, and physicians, for the diagnosis and management of acute conditions such as infections, strokes, and seizures? Finally, what are the most effective delivery methods and treatment outcomes for telemedicine and videoconferencing, including primary health care, general practice, rehabilitation, outpatients, and speech therapy, for the delivery of health care", "What is the effectiveness of telemedicine and videoconferencing in the delivery of primary health care, including rehabilitation and outpatient speech therapy, as compared to face-to-face visits and randomized controlled trials or clinical trials, in treating conditions such as diabetes, asthma, depression, and chronic fatigue?", "What are the benefits and drawbacks of using telemedicine or videoconferencing in the delivery of health care, including primary health care, rehabilitation, outpatients, and speech therapy, as compared to traditional face-to-face care or placebo interventions, as evaluated in randomized controlled trials or controlled clinical trials? Additionally, what are the clinical outcomes and treatment effectiveness of telemedicine or videoconferencing, as compared to face-to-face care or placebo interventions, as evaluated in randomized controlled trials or controlled clinical trials? Finally, what is the effectiveness of telemedicine or videoconferencing, as compared to face-to-face care or placebo interventions, in the diagnosis and management of chronic fatigue or PTSD, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of telemedicine, videoconferencing, and telehealth in the delivery of primary health care, general practice, rehabilitation, outpatients, and speech therapy? This includes randomized controlled trials, controlled clinical trials, randomized, placebo, drug therapy, and other treatment outcomes as evaluated by primary health care practitioners. Additionally, what is the effectiveness of telemedicine, videoconferencing, and telehealth in the diagnosis and management of clinical outcomes, including IBS, PTSD, and chronic fatigue, as evaluated by primary health care practitioners? Finally, what is the impact of telemedicine, videoconferencing, and telehealth on patient satisfaction, as evaluated by primary health care practitioners?", "What is the effectiveness of telemedicine and videoconferencing in the delivery of primary health care, including rehabilitation, outpatients, and speech therapy? This question can be answered by randomized controlled trials or controlled clinical trials, as well as placebo or drug therapy, and should also consider patient satisfaction and diagnostic accuracy. Additionally, what is the delivery of health care and treatment outcome, including randomized controlled trials or controlled clinical trials, as well as placebo or drug therapy, and should also consider patient satisfaction and diagnostic accuracy?"]}
{"id": "18", "boolean": "((\"Kidney Transplantation\"[Mesh] OR \"Kidney Transplantation\"[tiab] OR \"Kidney Transplantations\"[tiab] OR \"Kidney Transplant\"[tiab] OR \"Kidney Transplants\"[tiab] OR \"Kidney Procurement\"[tiab] OR \"Kidney Procurements\"[tiab] OR \"Kidney Donation\"[tiab] OR \"Kidney Donations\"[tiab] OR \"Kidney donor\"[tiab] OR \"Kidney donors\"[tiab]) AND (\"Transplants\"[Mesh] OR \"transplantation\"[sh] OR \"Transplant Recipients\"[Mesh] OR \"Transplant Donor Site\"[Mesh] OR \"Organ Transplantation\"[Mesh] OR Transplant[tiab] OR Transplantation[tiab] OR Transplants[tiab] OR Transplantations[tiab]) AND (Promote[tiab] OR Law[tiab] OR Laws[tiab] OR Legislation[tiab] OR Champion[tiab] OR Champions[tiab] OR Pursuit[tiab] OR \"Promotion program\"[tiab] OR \"Promotion programs\"[tiab] OR \"Donation program\"[tiab] OR \"Donation programs\"[tiab] OR \"Transplantation program\"[tiab] OR \"Transplantation programs\"[tiab] OR \"Educational program\"[tiab] OR \"Educational programs\"[tiab] OR Application[tiab]) AND (Increase[tiab] OR Increased[tiab] OR Higher[tiab] OR Improved[tiab] OR Rate[tiab] OR Rates[tiab]) AND (\"randomized controlled trial\"[pt] OR \"controlled clinical trial\"[pt] OR randomized[tiab] OR randomised[tiab] OR placebo[tiab] OR randomly[tiab] OR trial[tiab] OR groups[tiab] OR \"Epidemiologic Studies\"[Mesh] OR \"case-control studies\"[Mesh] OR \"Cohort Studies\"[Mesh] OR \"case control\"[tiab] OR Cohort[tiab] OR \"Follow up\"[tiab] OR Prospective[tiab] OR retrospective[tiab] OR Analysis[tiab] OR Implementation[tiab] OR Evaluated[tiab] OR Statistics[tiab] OR Data[tiab] OR \"statistics and numerical data\"[sh]))", "generated_query": ["What is the effectiveness of kidney transplantation, including promotion programs and educational materials, in increasing the transplant rate or improving the outcome of transplant recipients, as evaluated by randomized controlled trials or cohort studies, and with promotion programs and educational materials that increase awareness and understanding of kidney transplantation?", "What is the effectiveness of kidney transplantation, including transplants from living donors, as a treatment for end-stage renal disease? This includes the promotion and education of transplantation, as well as randomized controlled trials and follow-up studies, to improve the rate and quality of transplants.", "What is the effectiveness of kidney transplantation and related procedures, including donation, education, and legislation, in improving kidney function and preventing related complications? Additionally, what is the effectiveness of randomized controlled trials and epidemiologic studies in evaluating the impact of these procedures on the kidney transplantation process?", "What is the effectiveness of kidney transplantation and organ transplantation in general, as well as promotion programs and randomized controlled trials, in improving outcomes for patients and donors?", "What is the effectiveness of kidney transplantation, including promotional and educational programs, in increasing the rate of transplantations and recipient success, as evaluated in randomized controlled trials and follow-up studies?", "What is the effectiveness of kidney transplantation, including transplants and donation programs, as compared to placebo or other treatments, in reducing morbidity and mortality in both kidney transplant recipients and donors? Additionally, what is the impact of transplantation programs, including legislation, championships, pursuit, and education, on the rates and effectiveness of transplants?", "What is the effectiveness of kidney transplantation and transplant recipients in promoting organ donation, as compared to placebo or other interventions, in increasing the rate of kidney transplants and associated outcomes, including transplant recipients and donors, as evaluated in randomized controlled trials or controlled clinical trials?", "What is the effectiveness of kidney transplantation, including transplants, promote, laws, legislation, champion, pursuit, donation program, and randomized controlled trials or placebo-controlled studies, in improving the health and life expectancy of transplant recipients?", "What are the most effective kidney transplantation programs, including the promotion of organ donation, randomized controlled trials, and epidemiologic studies, for improving the success and complications of kidney transplantation, as well as the rate and effectiveness of donation programs?", "What is the effectiveness of kidney transplantation, including transplants from deceased donors, as compared to dialysis or other treatments, in improving survival or quality of life in patients with end-stage renal failure? This is a question that has been investigated by randomized controlled trials and epidemiologic studies, and the results have shown that kidney transplantation is a viable option for these patients."]}
